| class name | count |
|---|---|
| rosids | 692 |
| asterids | 412 |
| Liliopsida | 174 |
| Spermatophyta | 94 |
| eudicotyledons | 51 |
| Euphyllophyta | 45 |
| Magnoliophyta | 16 |
| Embryophyta | 2 |
| class name | count |
|---|---|
|
Lamiaceae
|
229 |
|
Fabaceae
|
141 |
|
Rosaceae
|
127 |
|
Poaceae
|
117 |
|
Brassicaceae
|
94 |
|
Cucurbitaceae
|
80 |
|
Euphorbiaceae
|
73 |
|
Asteraceae
|
64 |
|
Podocarpaceae
|
48 |
|
Convolvulaceae
|
47 |
|
Pinaceae
|
41 |
|
Rutaceae
|
36 |
|
Thymelaeaceae
|
35 |
|
Nectriaceae
|
31 |
|
Elsinoaceae
|
31 |
|
Malvaceae
|
27 |
|
Amaranthaceae
|
23 |
|
Cibotiaceae
|
15 |
|
Hyacinthaceae
|
14 |
|
Caryophyllaceae
|
14 |
| br08003 Category | # of metabolite |
|---|---|
| Gibberellins | 23 |
| Others | 32 |
| Kaurenes | 10 |
| Tiglianes | 12 |
| Daphnanes | 13 |
| Podocarpanes | 2 |
| KCF-S ID | # of metabolite |
|---|---|
| No. 40 | 81 |
| No. 63 | 67 |
| No. 159 | 33 |
| No. 187 | 32 |
| No. 203 | 27 |
| No. 241 | 27 |
| No. 289 | 23 |
| No. 323 | 21 |
| No. 401 | 19 |
| No. 531 | 15 |
| No. 463 | 13 |
| No. 689 | 12 |
| No. 757 | 12 |
| No. 874 | 10 |
| No. 862 | 10 |
| No. 1038 | 9 |
| No. 999 | 8 |
| No. 1267 | 8 |
| No. 1235 | 7 |
| No. 1817 | 6 |
| No. 1854 | 6 |
| No. 2074 | 5 |
| No. 2113 | 5 |
| No. 1841 | 4 |
| No. 3035 | 4 |
| No. 1155 | 3 |
| No. 3700 | 3 |
| No. 3698 | 3 |
| No. 3772 | 3 |
| No. 3185 | 3 |
| No. 4968 | 2 |
| No. 4826 | 2 |
| No. 4689 | 2 |
| No. 4995 | 2 |
| No. 5654 | 2 |
| No. 5420 | 2 |
| No. 5430 | 2 |
| No. 6255 | 1 |
| No. 8400 | 1 |
| No. 6940 | 1 |
| No. 5835 | 1 |
| No. 8155 | 1 |
| No. 6514 | 1 |
| KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
figure |
|---|---|---|---|---|---|---|---|
|
C00000001
|
GA34
/ Gibberellin A34 |
No. 40 |
|
||||
|
C00000003
|
GA47
/ Gibberellin A47 |
No. 40 |
|
||||
|
C00000004
|
GA90
/ Gibberellin A90 |
No. 40 |
|
||||
|
C00000005
|
GA54
/ Gibberellin A54 |
No. 40 |
|
||||
|
C00000006
|
GA58
/ Gibberellin A58 |
No. 40 |
|
||||
|
C00000007
|
GA71
/ Gibberellin A71 |
No. 40 |
|
||||
|
C00000008
|
GA35
/ Gibberellin A35 |
No. 40 |
|
||||
|
C00000009
|
GA48
/ Gibberellin A48 |
No. 40 |
|
||||
|
C00006244
|
Stemar-13-ene
|
No. 40 |
|
||||
|
C00007332
|
GA112
/ Gibberellin A112 |
No. 40 |
|
||||
|
C00007866
|
GA74
/ Gibberellin A74 |
No. 40 |
|
||||
|
C00000015
|
GA61
/ Gibberellin A61 |
No. 40 |
|
||||
|
C00007867
|
GA14
/ Gibberellin A14 |
No. 40 |
|
||||
|
C00007868
|
GA110
/ Gibberellin A110 |
No. 40 |
|
||||
|
C00007869
|
GA12
/ Gibberellin A12 |
C048462
|
No. 40 |
|
|||
|
C00000020
|
GA51
/ Gibberellin A51 |
No. 40 |
|
||||
|
C00000022
|
GA9
/ Gibberellin A9 |
No. 40 |
|
||||
|
C00007870
|
GA36
/ Gibberellin A36 |
No. 40 |
|
||||
|
C00007871
|
GA24
/ Gibberellin A24 |
C120176
|
No. 40 |
|
|||
|
C00007876
|
GA123
/ Gibberellin A123 |
No. 40 |
|
||||
|
C00000026
|
GA45
/ Gibberellin A45 |
No. 40 |
|
||||
|
C00000027
|
GA63
/ Gibberellin A63 |
No. 40 |
|
||||
|
C00013594
|
GA19
/ Gibberellin A19 |
C120175
|
No. 40 |
|
|||
|
C00000029
|
GA33
/ Gibberellin A33 |
No. 40 |
|
||||
|
C00000030
|
GA26
/ Gibberellin A26 |
No. 40 |
|
||||
|
C00000031
|
GA7
/ Gibberellin A7 |
No. 40 |
|
||||
|
C00000032
|
GA62
/ Gibberellin A62 |
No. 40 |
|
||||
|
C00000033
|
GA120
/ Gibberellin A120 |
No. 40 |
|
||||
|
C00000034
|
GA121
/ Gibberellin A121 |
No. 40 |
|
||||
|
C00000035
|
GA122
/ Gibberellin A122 |
No. 40 |
|
||||
|
C00017048
|
GA23
/ Gibberellin A23 |
No. 40 |
|
||||
|
C00000037
|
GA80
/ Gibberellin A80 |
No. 40 |
|
||||
|
C00000038
|
GA30
/ Gibberellin A30 |
No. 40 |
|
||||
|
C00001505
|
Glabcensin V
/ (+)-Gesneroidin F |
No. 40 |
|
||||
|
C00000040
|
GA32
/ Gibberellin A32 |
No. 40 |
|
||||
|
C00001499
|
Melissoidesin G
/ (-)-Melissoidesin G |
CHEMBL514251
|
No. 40 |
|
|||
|
C00000749
|
Adenanthin K
/ (-)-Adenanthin K |
CHEMBL468548
|
No. 40 |
|
|||
|
C00000044
|
GA1
/ Gibberellin A1 |
C422660
|
No. 40 |
|
|||
|
C00000045
|
GA29
/ Gibberellin A29 |
No. 40 |
|
||||
|
C00000574
|
Adenanthin J
/ (-)-Adenanthin J |
CHEMBL468391
|
No. 40 |
|
|||
|
C00000047
|
GA20
/ Gibberellin A20 |
No. 40 |
|
||||
|
C00000048
|
GA77
/ Gibberellin A77 |
No. 40 |
|
||||
|
C00000049
|
GA8
/ Gibberellin A8 |
No. 40 |
|
||||
|
C00000050
|
GA56
/ Gibberellin A56 |
No. 40 |
|
||||
|
C00000051
|
GA91
/ Gibberellin A91 |
No. 40 |
|
||||
|
C00000052
|
GA55
/ Gibberellin A55 |
No. 40 |
|
||||
|
C00000431
|
Adenanthin D
/ (+)-Adenanthin D |
No. 40 |
|
||||
|
C00000054
|
GA72
/ Gibberellin A72 |
No. 40 |
|
||||
|
C00000055
|
GA76
/ Gibberellin A76 |
No. 40 |
|
||||
|
C00000056
|
GA67
/ Gibberellin A67 |
No. 40 |
|
||||
|
C00000058
|
GA75
/ Gibberellin A75 |
No. 40 |
|
||||
|
C00000060
|
GA86
/ Gibberellin A86 |
No. 40 |
|
||||
|
C00000061
|
GA89
/ Gibberellin A89 |
No. 40 |
|
||||
|
C00000062
|
GA6
/ Gibberellin A6 |
No. 40 |
|
||||
|
C00000063
|
GA93
/ Gibberellin A93 |
No. 40 |
|
||||
|
C00000064
|
GA5
/ Gibberellin A5 |
No. 40 |
|
||||
|
C00000299
|
Forrestin C
/ (-)-Forrestin C |
CHEMBL512631
|
No. 40 |
|
|||
|
C00000295
|
Melissoidesin U
/ (+)-Melissoidesin U |
CHEMBL463161
|
No. 40 |
|
|||
|
C00000067
|
GA3
/ Gibberellin A3 |
CHEMBL513241
CHEMBL566653 CHEMBL1232952 CHEMBL1476967 CHEMBL1487394 |
C007842
|
10 / 18 / 17 | No. 40 |
|
|
|
C00000068
|
GA92
/ Gibberellin A92 |
No. 40 |
|
||||
|
C00000069
|
GA126
/ Gibberellin A126 |
No. 40 |
|
||||
|
C00000070
|
GA87
/ Gibberellin A87 |
No. 40 |
|
||||
|
C00000071
|
GA113
/ Gibberellin A113 |
No. 40 |
|
||||
|
C00000072
|
GA114
/ Gibberellin A114 |
No. 40 |
|
||||
|
C00000294
|
Melissoidesin R
/ (-)-Melissoidesin R |
CHEMBL462952
|
No. 40 |
|
|||
|
C00000075
|
GA64
/ Gibberellin A64 |
No. 40 |
|
||||
|
C00000076
|
GA37
/ Gibberellin A37 |
No. 40 |
|
||||
|
C00000077
|
GA27
/ Gibberellin A27 |
No. 40 |
|
||||
|
C00000079
|
GA38
/ Gibberellin A38 |
No. 40 |
|
||||
|
C00000080
|
GA98
/ Gibberellin A98 |
No. 40 |
|
||||
|
C00000081
|
GA124
/ Gibberellin A124 |
No. 40 |
|
||||
|
C00000082
|
GA44
/ Gibberellin A44 |
No. 40 |
|
||||
|
C00000228
|
Glabcensin C
/ (-)-Glabcensin C |
No. 40 |
|
||||
|
C00000084
|
GA52
/ Gibberellin A52 |
No. 40 |
|
||||
|
C00000085
|
GA106
/ Gibberellin A106 |
No. 40 |
|
||||
|
C00000086
|
GA107
/ Gibberellin A107 |
No. 40 |
|
||||
|
C00000087
|
GA104
/ Gibberellin A104 |
No. 40 |
|
||||
|
C00000089
|
GA108
/ Gibberellin A108 |
No. 40 |
|
||||
|
C00000090
|
GA105
/ Gibberellin A105 |
No. 40 |
|
||||
|
C00000216
|
GA103
/ Gibberellin A103 |
No. 40 |
|
||||
|
C00000224
|
GA82
/ Gibberellin A82 |
No. 40 |
|
||||
|
C00043700
|
Clerodinin C
|
No. 63 |
|
||||
|
C00040972
|
13S-Preperegrinine
/ (+)-13S-Preperegrinine |
No. 63 |
|
||||
|
C00040974
|
(13S)-Premarrubiin
|
No. 63 |
|
||||
|
C00040975
|
(13R)-Premarrubiin
|
C105732
|
No. 63 |
|
|||
|
C00040976
|
15-veratroyl-17-acetyl-19-oxodictizine
|
No. 63 |
|
||||
|
C00040978
|
Velutine B
|
No. 63 |
|
||||
|
C00040979
|
Velutine A
|
No. 63 |
|
||||
|
C00040980
|
15-epi-Cyllenine A
|
CHEMBL1078062
CHEMBL1078156 CHEMBL1078069 CHEMBL1078070 |
No. 63 |
|
|||
|
C00040985
|
Cyllenin A
|
CHEMBL1078062
CHEMBL1078156 CHEMBL1078069 CHEMBL1078070 |
No. 63 |
|
|||
|
C00040986
|
Cyllenine A
|
CHEMBL1078062
CHEMBL1078156 CHEMBL1078069 CHEMBL1078070 |
No. 63 |
|
|||
|
C00041069
|
15-epi-Cyllenin A
|
CHEMBL1078062
CHEMBL1078156 CHEMBL1078069 CHEMBL1078070 |
No. 63 |
|
|||
|
C00041218
|
Euphoscopin J
|
No. 63 |
|
||||
|
C00049653
|
Phorbol
|
CHEMBL124518
|
C033085
|
No. 63 |
|
||
|
C00049652
|
Lathyrol
|
No. 63 |
|
||||
|
C00049649
|
Jolkinol D
|
CHEMBL2315610
|
1 / 1 / 0 | No. 63 |
|
||
|
C00049647
|
Resiniferatoxin
|
C024353
|
3 / 11 | No. 63 |
|
||
|
C00049207
|
Inumakilactone A glycoside
|
No. 63 |
|
||||
|
C00049206
|
Ponalactone A glucoside
/ O-beta-D-Glucosyl ponalactone A |
No. 63 |
|
||||
|
C00049205
|
Albopilosin J
/ (-)-Albopilosin J |
CHEMBL463147
|
No. 63 |
|
|||
|
C00049204
|
Mascaroside
|
No. 63 |
|
||||
|
C00049083
|
3beta-Hydroxysolanascone beta-sophoroside
|
No. 63 |
|
||||
|
C00049000
|
Kansuiphorin D
|
No. 63 |
|
||||
|
C00048999
|
Kansuiphorin C
|
No. 63 |
|
||||
|
C00040970
|
1,9-Dideoxy-7-deacetylforskolin
|
No. 63 |
|
||||
|
C00040969
|
6beta,7beta,9alpha-Trihydroxy-8,13-epoxy-labd-14-en-11-one
|
No. 63 |
|
||||
|
C00043441
|
Euphoscopin F
|
No. 63 |
|
||||
|
C00040968
|
Deacetylforskolin
|
CHEMBL486619
|
C055628
|
No. 63 |
|
||
|
C00043699
|
Euphoheliosnoid D
|
No. 63 |
|
||||
|
C00040971
|
Preperegrinin
|
No. 63 |
|
||||
|
C00040967
|
Coleol
/ 8,13-Epoxy-9alpha-hydroxylabd-14-en-11-one |
No. 63 |
|
||||
|
C00040966
|
Coleosol
|
No. 63 |
|
||||
|
C00040965
|
9-Deoxyforskolin
|
No. 63 |
|
||||
|
C00048998
|
Zoapatanol
|
CHEMBL448102
CHEMBL166575 |
No. 63 |
|
|||
|
C00043701
|
Clerodinin D
|
No. 63 |
|
||||
|
C00048997
|
Montanol
|
CHEMBL424461
CHEMBL350928 |
C047278
|
No. 63 |
|
||
|
C00048991
|
Tomentol
|
No. 63 |
|
||||
|
C00043704
|
11-Episcutecolumnin C
/ (+)-11-Episcutecolumnin C |
No. 63 |
|
||||
|
C00043706
|
Scutecolumnin C
|
No. 63 |
|
||||
|
C00043707
|
Scutalbin C
|
No. 63 |
|
||||
|
C00043708
|
Scutalbin A
/ (-)-Scutalbin A |
No. 63 |
|
||||
|
C00043709
|
Jodrellin A
|
No. 63 |
|
||||
|
C00040964
|
1,9-Dideoxyforskolin
|
CHEMBL343846
CHEMBL519570 |
C047983
|
No. 63 |
|
||
|
C00040958
|
Coleonol E
|
CHEMBL343846
CHEMBL519570 |
No. 63 |
|
|||
|
C00043710
|
Scutebarbatine I
/ (-)-Scutebarbatine I |
No. 63 |
|
||||
|
C00040909
|
Coleonol F
|
No. 63 |
|
||||
|
C00040908
|
Coleonol D
/ Forskolin F |
No. 63 |
|
||||
|
C00040907
|
Coleonol
/ Forskolin |
CHEMBL52606
CHEMBL147623 CHEMBL1358402 CHEMBL1398667 CHEMBL1414148 CHEMBL1473060 CHEMBL1904897 CHEMBL1990053 |
46 / 40 / 28 | No. 63 |
|
||
|
C00040906
|
Coleonol C
|
CHEMBL147617
CHEMBL1519619 |
5 / 12 / 5 | No. 63 |
|
||
|
C00040905
|
Coleonol B
/ Isoforskolin |
CHEMBL147617
CHEMBL1519619 |
5 / 12 / 5 | No. 63 |
|
||
|
C00040862
|
ent-9alpha,13R-Epoxy-18-hydroxy-14-labden-7-one
|
No. 63 |
|
||||
|
C00031813
|
Macrocalyxin J
|
No. 63 |
|
||||
|
C00032521
|
Sculponin I
/ (-)-Sculponin I |
CHEMBL1079901
CHEMBL1080243 |
No. 63 |
|
|||
|
C00037879
|
15-Hydroxy-6-en-dehydroabietic acid
/ (-)-15-Hydroxy-6-en-dehydroabietic acid |
No. 63 |
|
||||
|
C00039417
|
Podolactone D
|
CHEMBL460334
|
No. 63 |
|
|||
|
C00039415
|
Podolide
|
CHEMBL465652
|
C009929
|
No. 63 |
|
||
|
C00045202
|
Atisenol
|
No. 63 |
|
||||
|
C00045203
|
Spiramilactone B
|
No. 63 |
|
||||
|
C00045204
|
7beta,12alpha-Dihydroxykaurenolide
|
No. 63 |
|
||||
|
C00045205
|
Doianoterpene A
/ (-)-Doianoterpene A |
No. 63 |
|
||||
|
C00045206
|
Doianoterpene B
/ (-)-Doianoterpene B |
No. 63 |
|
||||
|
C00045207
|
Mitrekaurenone
|
CHEMBL1079779
|
No. 63 |
|
|||
|
C00045208
|
Lucilianoside C
/ (-)-Lucilianoside C |
No. 63 |
|
||||
|
C00003438
|
Adenanthin H
/ (-)-Adenanthin H |
No. 63 |
|
||||
|
C00045209
|
Rebaudioside A
|
C025474
|
No. 63 |
|
|||
|
C00045210
|
Rebaudioside E
|
No. 63 |
|
||||
|
C00045211
|
Rebaudioside C
/ (-)-Rebaudioside C |
No. 63 |
|
||||
|
C00037878
|
7-Oxodehydroabietic acid
/ 7-Ketodehydroabietic acid |
CHEMBL597919
|
C095375
|
1 / 1 / 1 | No. 63 |
|
|
|
C00040101
|
Inumakilactone A
|
No. 159 |
|
||||
|
C00037103
|
Abieta-8,11,13,15-tetraen-18-oic acid
|
No. 159 |
|
||||
|
C00037102
|
Podocarpic acid
|
CHEMBL421115
CHEMBL2220581 |
C002470
|
8 / 4 / 1 | No. 159 |
|
|
|
C00038867
|
Montanin
|
CHEMBL451572
|
C024716
|
No. 159 |
|
||
|
C00035602
|
Pseurata F
|
CHEMBL551316
|
No. 159 |
|
|||
|
C00035595
|
Excisusin E
/ (-)-Excisusin E |
CHEMBL376605
|
No. 159 |
|
|||
|
C00035512
|
Xindongnin H
/ (-)-Xindongnin H |
CHEMBL2334483
|
No. 159 |
|
|||
|
C00000889
|
Melissoidesin S
/ (-)-Melissoidesin S |
CHEMBL463160
|
No. 159 |
|
|||
|
C00000897
|
Inflexinol
|
No. 159 |
|
||||
|
C00034841
|
Leukamenin E
|
CHEMBL562257
|
No. 159 |
|
|||
|
C00047231
|
ent-kaur-16-en-13,19-diol
/ (-)-ent-kaur-16-en-13,19-diol |
CHEMBL462774
|
No. 159 |
|
|||
|
C00034840
|
ent-1alpha-Acetoxy-7beta,14alpha-dihydroxykaur-16-en-15-one
/ (-)-ent-1alpha-Acetoxy-7beta,14alpha-dihydroxykaur-16-en-15-one |
CHEMBL252112
|
No. 159 |
|
|||
|
C00046739
|
Kaur-16-en-19-oic acid
/ ent-Kauren-19-oic acid |
CHEMBL523791
CHEMBL480983 CHEMBL1076299 CHEMBL1968150 |
C014341
|
1 / 0 / 0 | No. 159 |
|
|
|
C00034463
|
Melissoidesin N
/ (-)-Melissoidesin N |
CHEMBL462975
|
No. 159 |
|
|||
|
C00034462
|
Inflexanin A
|
CHEMBL225489
|
No. 159 |
|
|||
|
C00000879
|
Glabcensin O
/ (-)-Glabcensin O |
No. 159 |
|
||||
|
C00048345
|
Wikstroelide N
/ (+)-Wikstroelide N |
No. 159 |
|
||||
|
C00032939
|
Sculponeatin A
/ (-)-Sculponeatin A |
C055674
|
No. 159 |
|
|||
|
C00042213
|
Euphornin A
|
No. 159 |
|
||||
|
C00049865
|
Spruceanol
|
CHEMBL451294
|
C024715
|
No. 159 |
|
||
|
C00047855
|
Euphohelioscopin A
|
No. 159 |
|
||||
|
C00031762
|
Rabdosin B
/ (+)-Rabdosin B |
C037018
|
No. 159 |
|
|||
|
C00043945
|
3alpha-Hydroxymarrubiin
/ (+)-3alpha-Hydroxymarrubiin |
No. 159 |
|
||||
|
C00049866
|
Cleistanthol
|
No. 159 |
|
||||
|
C00048536
|
Pimelea factor P2
|
CHEMBL507954
CHEMBL506196 CHEMBL506890 CHEMBL506751 |
No. 159 |
|
|||
|
C00048534
|
Synaptolepis factor K1
|
No. 159 |
|
||||
|
C00048385
|
Mancinellin
|
CHEMBL502052
|
No. 159 |
|
|||
|
C00048384
|
Baliospermin
|
No. 159 |
|
||||
|
C00030180
|
6beta,7beta,16alpha,17-Tetrahydroxy-ent-kauranoic acid
/ ent-6alpha,7alpha,16beta,17-Tetrahydroxykauranoic acid / (-)-6beta,7beta,16alpha,17-Tetrahydroxy-ent-kauranoic acid |
No. 159 |
|
||||
|
C00007360
|
GA116
/ Gibberellin A116 |
No. 159 |
|
||||
|
C00048344
|
Wikstroelide M
|
No. 159 |
|
||||
|
C00007253
|
GA111
/ Gibberellin A111 / 12alpha-Hydroxygibberellin A12 |
No. 159 |
|
||||
|
C00040102
|
Sellowin A
|
CHEMBL1981967
|
C009231
|
No. 159 |
|
||
|
C00000043
|
GA118
/ Gibberellin A118 |
No. 187 |
|
||||
|
C00007254
|
GA112
/ Gibberellin A112 |
No. 187 |
|
||||
|
C00000046
|
GA81
/ Gibberellin A81 |
No. 187 |
|
||||
|
C00000041
|
GA60
/ Gibberellin A60 |
No. 187 |
|
||||
|
C00007865
|
GA115
/ Gibberellin A115 |
No. 187 |
|
||||
|
C00000053
|
GA85
/ Gibberellin A85 |
No. 187 |
|
||||
|
C00000039
|
GA68
/ Gibberellin A68 |
No. 187 |
|
||||
|
C00000036
|
GA31
/ Gibberellin A31 |
No. 187 |
|
||||
|
C00000028
|
GA94
/ Gibberellin A94 |
No. 187 |
|
||||
|
C00000065
|
GA95
/ Gibberellin A95 |
No. 187 |
|
||||
|
C00000025
|
GA84
/ Gibberellin A84 |
No. 187 |
|
||||
|
C00007873
|
GA65
/ Gibberellin A65 |
No. 187 |
|
||||
|
C00007874
|
GA18
/ Gibberellin A18 |
No. 187 |
|
||||
|
C00007875
|
GA97
/ Gibberellin A97 |
No. 187 |
|
||||
|
C00000024
|
GA70
/ Gibberellin A70 |
No. 187 |
|
||||
|
C00000066
|
GA22
/ Gibberellin A22 |
No. 187 |
|
||||
|
C00017047
|
GA53
/ Gibberellin A53 |
No. 187 |
|
||||
|
C00000074
|
GA15
/ Gibberellin A15 |
No. 187 |
|
||||
|
C00017049
|
GA99
/ Gibberellin A99 |
No. 187 |
|
||||
|
C00000083
|
GA101
/ Gibberellin A101 |
No. 187 |
|
||||
|
C00000023
|
GA69
/ Gibberellin A69 |
No. 187 |
|
||||
|
C00044171
|
Marrubiin
|
CHEMBL1444915
CHEMBL1999372 |
C105731
|
5 / 1 / 4 | No. 187 |
|
|
|
C00000019
|
GA40
/ Gibberellin A40 |
No. 187 |
|
||||
|
C00000018
|
GA4
/ Gibberellin A4 |
No. 187 |
|
||||
|
C00000017
|
GA119
/ Gibberellin A119 |
No. 187 |
|
||||
|
C00001210
|
Adenanthin G
/ (-)-Adenanthin G |
No. 187 |
|
||||
|
C00000298
|
Adenanthin B
|
No. 187 |
|
||||
|
C00000013
|
GA50
/ Gibberellin A50 |
No. 187 |
|
||||
|
C00000012
|
GA49
/ Gibberellin A49 |
No. 187 |
|
||||
|
C00000317
|
Calcicolin D
/ (-)-Calcicolin D |
No. 187 |
|
||||
|
C00000324
|
Calcicolin E
/ (-)-Calcicolin E |
No. 187 |
|
||||
|
C00000014
|
GA79
/ Gibberellin A79 |
No. 187 |
|
||||
|
C00035596
|
Pseurata C
|
CHEMBL483119
|
No. 203 |
|
|||
|
C00000887
|
Calcicolin C
/ (-)-Calcicolin C |
No. 203 |
|
||||
|
C00000898
|
Adenanthin F
/ (-)-Adenanthin F |
CHEMBL484246
|
No. 203 |
|
|||
|
C00037922
|
Wikstroelide A
/ (+)-Wikstroelide A |
CHEMBL499462
|
No. 203 |
|
|||
|
C00045643
|
Stevioside
|
CHEMBL25147
CHEMBL444122 |
C012043
|
3 / 2 / 1 | 0 / 1 | No. 203 |
|
|
C00037369
|
15-Hydroxydehydroabietic acid
|
CHEMBL598566
CHEMBL1348397 |
6 / 8 / 4 | No. 203 |
|
||
|
C00049686
|
Resiniferonol
|
CHEMBL521374
|
C035114
|
No. 203 |
|
||
|
C00049687
|
1,2-Dihydrodaphnetoxin
|
No. 203 |
|
||||
|
C00049689
|
Daphnetoxin
|
CHEMBL2023369
|
C452759
|
No. 203 |
|
||
|
C00049850
|
Kansuinin C
/ (+)-Kansuinin C |
CHEMBL504227
|
No. 203 |
|
|||
|
C00049852
|
Kansuinine B
|
CHEMBL448506
|
No. 203 |
|
|||
|
C00043944
|
Scutebarbatine J
/ (-)-Scutebarbatine J |
No. 203 |
|
||||
|
C00044314
|
Leonotinin
|
CHEMBL2036989
|
3 / 2 / 0 | No. 203 |
|
||
|
C00037923
|
Wikstroelide L
/ (+)-Wikstroelide L |
CHEMBL499462
|
No. 203 |
|
|||
|
C00040103
|
Podolactone C
|
CHEMBL465261
|
C008944
|
No. 203 |
|
||
|
C00045647
|
Pisumoside A
/ (-)-Pisumoside A |
No. 203 |
|
||||
|
C00045642
|
Dulcoside A
|
No. 203 |
|
||||
|
C00038650
|
Wikstroelide H
/ (+)-Wikstroelide H |
No. 203 |
|
||||
|
C00045520
|
Rebaudioside F
/ (-)-Rebaudioside F |
No. 203 |
|
||||
|
C00048562
|
Pimelotide A
/ (+)-Pimelotide A |
No. 203 |
|
||||
|
C00046613
|
Cunabic acid
/ ent-Kaurenoic acid / ent-Kaur-16-en-19-oic acid |
CHEMBL523791
CHEMBL480983 CHEMBL1076299 CHEMBL1968150 |
C051436
|
1 / 0 / 0 | No. 203 |
|
|
|
C00035038
|
Excisanin B
|
CHEMBL470766
CHEMBL2005542 |
No. 203 |
|
|||
|
C00038651
|
Kirkinine
/ (+)-Kirkinine |
CHEMBL502037
|
No. 203 |
|
|||
|
C00038652
|
Simplexin
|
CHEMBL444290
|
C011110
|
No. 203 |
|
||
|
C00047366
|
Sapintoxin A
|
CHEMBL503534
CHEMBL503800 |
C032016
|
No. 203 |
|
||
|
C00048380
|
(
/ Wikstroelide J / )-Wikstroelide J |
No. 203 |
|
||||
|
C00003423
|
Calcicolin B
/ (-)-Calcicolin B |
CHEMBL511941
|
No. 203 |
|
|||
|
C00003443
|
Canditriol
|
CHEMBL563968
|
2 / 1 / 0 | No. 241 |
|
||
|
C00035709
|
Dihydropseurata F
|
No. 241 |
|
||||
|
C00003424
|
Leucophyllin B
/ (-)-Leucophyllin B |
No. 241 |
|
||||
|
C00045067
|
Spiramilactone
|
No. 241 |
|
||||
|
C00048112
|
Nagilactone D
|
No. 241 |
|
||||
|
C00048111
|
Nagilactone B
|
CHEMBL1586581
|
19 / 26 / 18 | No. 241 |
|
||
|
C00048110
|
Sellowin C
|
No. 241 |
|
||||
|
C00048109
|
Nagilactone A
|
CHEMBL1381439
|
13 / 20 / 13 | No. 241 |
|
||
|
C00048105
|
Oryzalexin E
|
No. 241 |
|
||||
|
C00048104
|
Candidenodiol
/ (+)-Candidenodiol |
No. 241 |
|
||||
|
C00048103
|
Ineketone
|
No. 241 |
|
||||
|
C00048102
|
9alpha-Hydroxyisopimara-8(14),15-dien-7-one
/ (-)-9alpha-Hydroxyisopimara-8(14),15-dien-7-one |
No. 241 |
|
||||
|
C00035769
|
Lambertic acid
/ (+)-Lambertic acid |
CHEMBL519807
CHEMBL523920 |
1 / 1 / 1 | No. 241 |
|
||
|
C00048474
|
Wikstroelide E
/ (+)-Wikstroelide E |
No. 241 |
|
||||
|
C00031121
|
Trichorabdal B
/ (-)-Trichorabdal B |
CHEMBL250882
|
C090068
|
No. 241 |
|
||
|
C00039656
|
SR-Podolactone D
/ (+)-SR-Podolactone D |
CHEMBL460334
|
No. 241 |
|
|||
|
C00048542
|
Pimelotide B
/ (+)-Pimelotide B |
No. 241 |
|
||||
|
C00003481
|
ent-Kaurenol
|
CHEMBL512447
CHEMBL590263 |
No. 241 |
|
|||
|
C00031769
|
Loxothyrin A
|
CHEMBL486708
|
No. 241 |
|
|||
|
C00044895
|
Nepetefuran
|
No. 241 |
|
||||
|
C00031897
|
Sinuolatin E
/ (-)-Sinuolatin E |
No. 241 |
|
||||
|
C00031989
|
Oreskaurin A
/ (-)-Oreskaurin A |
No. 241 |
|
||||
|
C00036615
|
12,15-Dihydroxyabieta-8,11,13-trien-18-oic acid
|
No. 241 |
|
||||
|
C00036726
|
16-Hydroxycarnosic acid
|
No. 241 |
|
||||
|
C00037086
|
Angustanoic acid G
/ (+)-Angustanoic acid G |
No. 241 |
|
||||
|
C00037716
|
Angustanoic acid F
|
CHEMBL598566
CHEMBL1348397 |
6 / 8 / 4 | No. 241 |
|
||
|
C00040550
|
Hallactone B
|
No. 241 |
|
||||
|
C00039199
|
Gnidicin
|
CHEMBL49689
CHEMBL2023370 |
C010459
|
No. 289 |
|
||
|
C00043703
|
Clerodiol
|
No. 289 |
|
||||
|
C00042207
|
Euphornin B
|
CHEMBL463643
|
No. 289 |
|
|||
|
C00003442
|
3-Acetylcalcicolin A
|
No. 289 |
|
||||
|
C00032522
|
Sculponin J
/ (-)-Sculponin J |
CHEMBL1079901
CHEMBL1080243 |
No. 289 |
|
|||
|
C00047549
|
12-O-2Z,4E-Octadienoyl-4-deoxyphorbol 13-acetate
|
CHEMBL518848
CHEMBL519593 |
No. 289 |
|
|||
|
C00040098
|
Podolactone A
|
C008943
|
No. 289 |
|
|||
|
C00040973
|
Marrubinone B
/ (+)-Marrubinone B:Polyodonin |
No. 289 |
|
||||
|
C00047492
|
Pedilstatin
|
CHEMBL518848
CHEMBL519593 |
No. 289 |
|
|||
|
C00047253
|
ent-Kaur-16-en-13-hydroxy-19-al
/ (-)-ent-Kaur-16-en-13-hydroxy-19-al |
CHEMBL517756
|
No. 289 |
|
|||
|
C00039197
|
Gnididin
|
C010460
|
No. 289 |
|
|||
|
C00047254
|
Steviol
/ (-)-Steviol |
CHEMBL463996
CHEMBL1331260 |
C012042
|
5 / 3 / 2 | No. 289 |
|
|
|
C00047341
|
alpha-Sapinine
/ (-)-alpha-Sapinine |
CHEMBL503534
CHEMBL503800 |
No. 289 |
|
|||
|
C00039414
|
Nagilactone G
|
No. 289 |
|
||||
|
C00039413
|
Nagilactone E
|
CHEMBL519090
|
No. 289 |
|
|||
|
C00039202
|
Genkwadaphnin
/ (+)-Genkwadaphnin |
C036412
|
No. 289 |
|
|||
|
C00039198
|
Gniditrin
|
CHEMBL1159653
|
C010461
|
No. 289 |
|
||
|
C00039201
|
Mezerein
|
CHEMBL126750
CHEMBL1468786 CHEMBL2007127 |
C011309
|
14 / 16 / 11 | 4 / 3 | No. 289 |
|
|
C00032523
|
Sculponeatin C
/ (-)-Sculponeatin C |
CHEMBL1079532
|
No. 289 |
|
|||
|
C00047367
|
Sapintoxin B
|
CHEMBL504966
CHEMBL502699 |
No. 289 |
|
|||
|
C00030183
|
Sculponin G
/ (-)-Sculponin G |
CHEMBL1082072
CHEMBL1082073 |
No. 289 |
|
|||
|
C00047435
|
Sapintoxin C
|
CHEMBL505667
CHEMBL496712 |
No. 289 |
|
|||
|
C00030181
|
Broussonetone C
/ (-)-Broussonetone C |
No. 289 |
|
||||
|
C00029523
|
Annoglabasin B
|
CHEMBL490145
CHEMBL1288242 |
No. 323 |
|
|||
|
C00035978
|
12-Hydroxydehydroabietic acid
/ (+)-12-Hydroxydehydroabietic acid |
CHEMBL519807
CHEMBL523920 |
1 / 1 / 1 | No. 323 |
|
||
|
C00040858
|
6beta-Hydroxy-8,13-epoxy-labd-14-en-11-one
|
No. 323 |
|
||||
|
C00030622
|
Isodonal
|
CHEMBL453800
|
No. 323 |
|
|||
|
C00046986
|
ent-7beta-Hydroxykaurenoic acid
/ ent-7alpha-Hydroxykaur-16-en-19-oic acid |
No. 323 |
|
||||
|
C00036186
|
7beta-Hydroxyabieta-8,11,13-trien-18-oic acid
/ (+)-7beta-Hydroxyabieta-8,11,13-trien-18-oic acid |
CHEMBL604665
CHEMBL604787 |
No. 323 |
|
|||
|
C00029401
|
Helifulvanic acid
|
No. 323 |
|
||||
|
C00029387
|
Trachyloban-19-oic acid
/ (-)-Trachyloban-19-oic acid |
CHEMBL511801
CHEMBL463698 CHEMBL1164460 |
C039978
|
1 / 0 / 0 | No. 323 |
|
|
|
C00049990
|
Antheridic acid
/ Antheridiogen-An |
No. 323 |
|
||||
|
C00040773
|
Sellowin B
|
No. 323 |
|
||||
|
C00049989
|
Hymatoxin A
|
No. 323 |
|
||||
|
C00036880
|
16-nor-15-Oxoabieta-8,11,13-trien-18-oic acid
|
No. 323 |
|
||||
|
C00049984
|
Candletoxin A
|
No. 323 |
|
||||
|
C00040763
|
Inumakilactone B
|
No. 323 |
|
||||
|
C00034400
|
Glabcensin J
/ (-)-Glabcensin J |
No. 323 |
|
||||
|
C00049963
|
Atractyloside
|
CHEMBL499815
CHEMBL1440014 CHEMBL1742110 CHEMBL2028191 |
D001278
|
94 / 40 / 34 | No. 323 |
|
|
|
C00003470
|
Albopilosin G
/ (+)-Albopilosin G |
CHEMBL514404
|
No. 323 |
|
|||
|
C00048932
|
Tomentanol
|
No. 323 |
|
||||
|
C00042455
|
Euphoscopin C
|
CHEMBL506068
|
No. 323 |
|
|||
|
C00003474
|
Sicanadiol
|
No. 323 |
|
||||
|
C00047642
|
Euphorbia factor Ti2
|
No. 323 |
|
||||
|
C00003490
|
Excoecarin K
/ (-)-Excoecarin K |
No. 401 |
|
||||
|
C00003430
|
Glabcensin K
/ (-)-Glabcensin K |
No. 401 |
|
||||
|
C00003431
|
Melissoidesin C
/ (+)-Melissoidesin C |
No. 401 |
|
||||
|
C00049027
|
Ingenol 3,20-dibenzoate
|
CHEMBL347361
CHEMBL2165713 |
C011875
|
2 / 0 | No. 401 |
|
|
|
C00049028
|
Tripdiolide
|
CHEMBL486403
|
C001898
|
No. 401 |
|
||
|
C00049032
|
Triptriolide
|
No. 401 |
|
||||
|
C00049035
|
Ingenol 3-hexadecanoate
|
C019191
|
No. 401 |
|
|||
|
C00003482
|
ent-Kaur-16-en-19-ol
/ (-)-ent-Kaur-16-en-19-ol |
CHEMBL1760139
|
No. 401 |
|
|||
|
C00003432
|
Melissoidesin E
/ (+)-Melissoidesin E |
No. 401 |
|
||||
|
C00047057
|
Gibberellin A12 aldehyde
|
C048463
|
No. 401 |
|
|||
|
C00003455
|
Candol A
|
No. 401 |
|
||||
|
C00003454
|
7-Epicandicandiol
|
CHEMBL561846
|
2 / 1 / 0 | No. 401 |
|
||
|
C00044232
|
Ballotinone
/ 7-Oxomarrubiin |
No. 401 |
|
||||
|
C00003433
|
Melissoidesin Q
/ (-)-Melissoidesin Q |
CHEMBL517768
|
No. 401 |
|
|||
|
C00003435
|
Inflexarabdonin A
/ (-)-Inflexarabdonin A |
CHEMBL224140
|
No. 401 |
|
|||
|
C00039283
|
Gnididilatin
|
CHEMBL454006
|
No. 401 |
|
|||
|
C00047923
|
Mellerin A
/ (+)-Mellerin A |
No. 401 |
|
||||
|
C00039258
|
Hirsein B
|
CHEMBL562784
|
No. 401 |
|
|||
|
C00047922
|
Prostratin
|
CHEMBL170518
CHEMBL1980156 |
C070999
|
9 / 2 / 2 | No. 401 |
|
|
|
C00045075
|
Spiramilactone C
|
No. 463 |
|
||||
|
C00000281
|
Adenanthin
|
No. 463 |
|
||||
|
C00000280
|
Glabcensin Q
/ (-)-Glabcensin Q |
No. 463 |
|
||||
|
C00000277
|
Glabcensin A
/ (-)-Glabcensin A |
No. 463 |
|
||||
|
C00000275
|
Calcicolin A
|
CHEMBL468345
|
No. 463 |
|
|||
|
C00000274
|
Adenanthin C
|
CHEMBL482605
|
No. 463 |
|
|||
|
C00000272
|
Lungshengenin F
|
No. 463 |
|
||||
|
C00000266
|
Glabcensin F
/ (-)-Glabcensin F |
No. 463 |
|
||||
|
C00000265
|
Glabcensin D
/ (-)-Glabcensin D |
No. 463 |
|
||||
|
C00000285
|
Glabcensin L
/ (-)-Glabcensin L |
No. 463 |
|
||||
|
C00000264
|
Glabcensin E
/ (-)-Glabcensin E |
No. 463 |
|
||||
|
C00000263
|
Glabcensin G
/ (-)-Glabcensin G |
No. 463 |
|
||||
|
C00000284
|
Leucophyllin A(Rabdosia)
/ (-)-Leucophyllin A(Rabdosia) |
No. 463 |
|
||||
|
C00003416
|
Melissoidesin A
/ (-)-Melissoidesin A |
No. 531 |
|
||||
|
C00022264
|
GA39
/ Gibberellin A39 |
No. 531 |
|
||||
|
C00022265
|
GA43
/ Gibberellin A43 |
No. 531 |
|
||||
|
C00022283
|
GA28
/ Gibberellin A28 |
No. 531 |
|
||||
|
C00022263
|
GA66
/ Gibberellin A66 |
No. 531 |
|
||||
|
C00022286
|
GA41
/ Gibberellin A41 |
No. 531 |
|
||||
|
C00022387
|
Siegesbeckiol
|
No. 531 |
|
||||
|
C00022388
|
Suremulol A
/ (-)-Suremulol A |
No. 531 |
|
||||
|
C00022389
|
Vierol
|
CHEMBL1760128
|
No. 531 |
|
|||
|
C00022396
|
Annosquamosin C
/ (-)-Annosquamosin C |
No. 531 |
|
||||
|
C00022397
|
Stemarin
|
No. 531 |
|
||||
|
C00022262
|
GA25
/ Gibberellin A25 |
No. 531 |
|
||||
|
C00022460
|
Broussonetone A
/ (-)-Broussonetone A |
CHEMBL574312
CHEMBL574535 |
No. 531 |
|
|||
|
C00022461
|
Broussonetone B
/ (-)-Broussonetone B |
CHEMBL574312
CHEMBL574535 |
No. 531 |
|
|||
|
C00022284
|
GA83
/ Gibberellin A83 |
No. 531 |
|
||||
|
C00035207
|
Isodomedin
|
CHEMBL564759
|
No. 689 |
|
|||
|
C00035287
|
Isoscoparin E
/ (-)-Isoscoparin E |
No. 689 |
|
||||
|
C00048251
|
Hallactone A
|
C007900
|
No. 689 |
|
|||
|
C00035208
|
Albopilosin A
|
CHEMBL463148
|
No. 689 |
|
|||
|
C00023348
|
Diterpenoid SP-II
|
CHEMBL490353
CHEMBL517155 CHEMBL519801 CHEMBL482613 |
No. 689 |
|
|||
|
C00023347
|
Epiadejone
|
No. 689 |
|
||||
|
C00003476
|
ent-Atisir-16-ene
|
No. 689 |
|
||||
|
C00035423
|
Rabdokunmin A
|
CHEMBL564723
|
No. 689 |
|
|||
|
C00035424
|
Isoscoparin F
/ (+)-Isoscoparin F |
CHEMBL564818
|
No. 689 |
|
|||
|
C00033162
|
Sculponeatin D
|
CHEMBL1079358
|
No. 689 |
|
|||
|
C00041472
|
Euphoscopin B
|
No. 689 |
|
||||
|
C00041247
|
Euphornin G
|
No. 689 |
|
||||
|
C00030238
|
Ludongnin J
/ (-)-Ludongnin J |
CHEMBL513646
|
No. 757 |
|
|||
|
C00030237
|
Shikodonin
|
No. 757 |
|
||||
|
C00039182
|
Gnidilatidin
|
CHEMBL504425
|
C048261
|
No. 757 |
|
||
|
C00030232
|
Epinodosin
|
CHEMBL510160
CHEMBL1081333 |
No. 757 |
|
|||
|
C00030231
|
Sculponeatin B
/ (-)-Sculponeatin B |
CHEMBL1079531
|
No. 757 |
|
|||
|
C00039181
|
Hirsein A
/ (+)-Hirsein A |
CHEMBL553900
|
No. 757 |
|
|||
|
C00039180
|
Huratoxin
|
CHEMBL470375
CHEMBL1978920 |
C044222
|
No. 757 |
|
||
|
C00030239
|
Sculponeatin J
/ (-)-Sculponeatin J |
CHEMBL517010
|
No. 757 |
|
|||
|
C00030233
|
Rabdosin A
/ (-)-Rabdosin A |
C037017
|
No. 757 |
|
|||
|
C00030236
|
Angustifolin
/ (-)-Angustifolin |
CHEMBL517598
CHEMBL463922 |
No. 757 |
|
|||
|
C00030234
|
Enmein
|
CHEMBL453801
|
C007594
|
No. 757 |
|
||
|
C00030235
|
Enanderinanin F
/ 6-Epiangustifolin / (-)-Enanderinanin F |
CHEMBL517598
CHEMBL463922 |
No. 757 |
|
|||
|
C00042043
|
Euphornin C
|
No. 862 |
|
||||
|
C00042988
|
Euphoscopin E
|
No. 862 |
|
||||
|
C00003447
|
Eubotriol
|
CHEMBL563968
|
2 / 1 / 0 | No. 862 |
|
||
|
C00041114
|
Euphoscopin A
|
No. 862 |
|
||||
|
C00023520
|
16alpha,17-Dihydroxy-ent-kauran-19-oic acid
/ (-)-16alpha,17-Dihydroxy-ent-kauran-19-oic acid |
CHEMBL490353
CHEMBL517155 CHEMBL519801 CHEMBL482613 |
No. 862 |
|
|||
|
C00023521
|
16alpha,17-Dihydroxy-ent-kauran-19-oic acid
/ (-)-16alpha,17-Dihydroxy-ent-kauran-19-oic acid |
CHEMBL490353
CHEMBL517155 CHEMBL519801 CHEMBL482613 |
No. 862 |
|
|||
|
C00023522
|
Doianoterpene D
/ (-)-Doianoterpene D |
No. 862 |
|
||||
|
C00031332
|
Effusin
|
No. 862 |
|
||||
|
C00031333
|
Lushanrubescensin H
/ (+)-Lushanrubescensin H |
No. 862 |
|
||||
|
C00050230
|
Portulal
|
CHEMBL1999096
|
No. 862 |
|
|||
|
C00022217
|
GA13
/ Gibberellin A13 |
No. 874 |
|
||||
|
C00022218
|
GA46
/ Gibberellin A46 |
No. 874 |
|
||||
|
C00048283
|
Nagilactone C
|
CHEMBL176006
CHEMBL487996 |
C004552
|
No. 874 |
|
||
|
C00022266
|
GA17
/ Gibberellin A17 |
No. 874 |
|
||||
|
C00022384
|
Pterokaurane M3
/ (-)-Pterokaurane M3 |
No. 874 |
|
||||
|
C00022390
|
16alpha,19-Dihydroxy-ent-kaurane
|
CHEMBL1760128
|
No. 874 |
|
|||
|
C00022393
|
Annosquamosin G
|
No. 874 |
|
||||
|
C00022391
|
/ Kauranol / (-)-Kauran-16alpha-ol |
No. 874 |
|
||||
|
C00003452
|
Suremulol B
/ (-)-Suremulol B |
No. 874 |
|
||||
|
C00022392
|
Annosquamosin B
/ (-)-Annosquamosin B |
CHEMBL516819
|
No. 874 |
|
|||
|
C00035593
|
ent-18-Acetoxy-7beta-hydroxykaur-16-en-15-one
/ (-)-ent-18-Acetoxy-7beta-hydroxykaur-16-en-15-one |
CHEMBL254180
|
No. 999 |
|
|||
|
C00035594
|
Excisusin A
/ (-)-Excisusin A |
CHEMBL223544
|
No. 999 |
|
|||
|
C00047999
|
12-O-Palmitoyl-16-hydroxyphorbol 13-acetate
|
CHEMBL2012888
|
C028113
|
No. 999 |
|
||
|
C00024974
|
Trachyloban-18-oic acid
/ (-)-Trachyloban-18-oic acid |
CHEMBL511801
CHEMBL463698 CHEMBL1164460 |
1 / 0 / 0 | No. 999 |
|
||
|
C00024973
|
(-)-17-Hydroxy-16alpha-kauran-19-oic acid
|
CHEMBL511892
CHEMBL481645 CHEMBL448617 CHEMBL456957 |
No. 999 |
|
|||
|
C00003421
|
Xindongnin A
/ (-)-Xindongnin A |
No. 999 |
|
||||
|
C00024972
|
Annoglabasin E
/ (-)-Annoglabasin E |
CHEMBL1288269
|
No. 999 |
|
|||
|
C00024837
|
(-)-16alpha-Hydroxykauran-19-oic acid
|
CHEMBL207260
CHEMBL480070 CHEMBL604095 CHEMBL1760135 |
C060419
|
1 / 0 / 0 | No. 999 |
|
|
|
C00003485
|
ent-19-Hydroxykaur-16-en
|
CHEMBL253558
|
No. 1038 |
|
|||
|
C00036205
|
Carnosic acid
|
CHEMBL484853
CHEMBL1397655 |
C018381
|
17 / 23 / 55 | 6 / 4 | No. 1038 |
|
|
C00036204
|
O-Methylpisiferic acid
|
CHEMBL479111
|
No. 1038 |
|
|||
|
C00036203
|
12-O-methylcarnosic acid
/ 12-O-Methyl carnosic acid / (+)-12-O-Methyl carnosic acid / Carnosic acid 12-methyl ether |
CHEMBL1096627
|
No. 1038 |
|
|||
|
C00036133
|
Dehydroabietic acid
|
CHEMBL12850
|
C013913
|
No. 1038 |
|
||
|
C00036114
|
4beta-Carboxy-19-nortotarol
|
CHEMBL517672
|
No. 1038 |
|
|||
|
C00033308
|
7-O-Acetylpseurata C
/ (+)-7-O-Acetylpseurata C |
CHEMBL550161
|
No. 1038 |
|
|||
|
C00023175
|
Abbeokutone
|
CHEMBL437293
|
No. 1038 |
|
|||
|
C00037724
|
7-Oxo-15-hydroxydehydroabietic acid
|
CHEMBL597920
|
No. 1038 |
|
|||
|
C00000278
|
Glabcensin B
/ (-)-Glabcensin B |
No. 1155 |
|
||||
|
C00000267
|
Lungshengenin A
|
No. 1155 |
|
||||
|
C00000273
|
Lungshengenin C
/ (-)-Lungshengenin C |
CHEMBL522144
|
No. 1155 |
|
|||
|
C00034695
|
Excisusin B
/ (-)-Excisusin B |
CHEMBL389487
|
No. 1235 |
|
|||
|
C00039110
|
Mellerin B
/ (+)-Mellerin B |
No. 1235 |
|
||||
|
C00000877
|
Nervosanin
/ (+)-Nervosanin |
CHEMBL446517
|
No. 1235 |
|
|||
|
C00039111
|
Terpenoid EA-I
|
CHEMBL453030
CHEMBL447856 |
No. 1235 |
|
|||
|
C00000886
|
Melissoidesin D
/ (-)-Melissoidesin D |
No. 1235 |
|
||||
|
C00037368
|
Angustanoic acid E
|
No. 1235 |
|
||||
|
C00000881
|
Glabcensin P
/ (-)-Glabcensin P |
No. 1235 |
|
||||
|
C00003459
|
ent-Kaur-15-ene-17,19-diol
|
No. 1267 |
|
||||
|
C00044515
|
Leonotin
|
No. 1267 |
|
||||
|
C00046289
|
Nagilactone F
|
CHEMBL1765574
|
1 / 0 / 0 | No. 1267 |
|
||
|
C00045058
|
Nepetefuranol
|
No. 1267 |
|
||||
|
C00045059
|
7-Acetoxymarrubin
|
No. 1267 |
|
||||
|
C00003425
|
Inflexin
|
No. 1267 |
|
||||
|
C00030230
|
Sculponin H
/ (-)-Sculponin H |
CHEMBL1082072
CHEMBL1082073 |
No. 1267 |
|
|||
|
C00045060
|
Dubiin
|
No. 1267 |
|
||||
|
C00003491
|
ent-Beyer-15-en-18-ol
/ (+)-ent-Beyer-15-en-18-ol |
CHEMBL1979559
|
No. 1817 |
|
|||
|
C00003464
|
Episinfernal
|
No. 1817 |
|
||||
|
C00003466
|
ent-Kaur-15-en-17-ol
|
CHEMBL481119
|
C066409
|
No. 1817 |
|
||
|
C00040076
|
Podolactone B
|
No. 1817 |
|
||||
|
C00003422
|
Glabcensin X
/ (-)-Glabcensin X |
No. 1817 |
|
||||
|
C00044231
|
Peregrinin
|
CHEMBL1894171
|
No. 1817 |
|
|||
|
C00035983
|
Pisiferic acid
|
C060710
|
No. 1841 |
|
|||
|
C00034093
|
Inflexanin B
|
CHEMBL427086
|
No. 1841 |
|
|||
|
C00003437
|
Adenanthin E
/ (+)-Adenanthin E |
CHEMBL466139
|
No. 1841 |
|
|||
|
C00050032
|
Cafestol
|
CHEMBL31819
CHEMBL1407645 |
C053400
|
2 / 3 / 7 | 8 / 0 | No. 1841 |
|
|
C00000269
|
Melissoidesin B
/ (-)-Melissoidesin B |
No. 1854 |
|
||||
|
C00000270
|
Leucophyllin D
/ (+)-Leucophyllin D |
No. 1854 |
|
||||
|
C00000271
|
Dawoensin A
/ (-)-Dawoensin A |
CHEMBL456521
|
No. 1854 |
|
|||
|
C00000268
|
Weisiensin A
|
CHEMBL486058
CHEMBL1975980 |
No. 1854 |
|
|||
|
C00000276
|
Gesneroidin C
/ (-)-Gesneroidin C |
No. 1854 |
|
||||
|
C00000286
|
Glabcensin M
/ (-)-Glabcensin M |
No. 1854 |
|
||||
|
C00003451
|
Candidiol
|
No. 2074 |
|
||||
|
C00049036
|
Ingenol
|
CHEMBL346507
CHEMBL2165402 |
C008125
|
1 / 0 / 0 | No. 2074 |
|
|
|
C00049034
|
5-O-(2'E,4'E-Decadienoyl)ingenol
|
CHEMBL486879
|
No. 2074 |
|
|||
|
C00003406
|
Glabcensin H
/ (-)-Glabcensin H |
No. 2074 |
|
||||
|
C00033488
|
Excisusin D
/ (-)-Excisusin D |
CHEMBL388127
|
No. 2074 |
|
|||
|
C00048065
|
12-Tetradecanoylphorbol 13-acetate
|
CHEMBL291793
CHEMBL279115 CHEMBL1328542 CHEMBL1441758 CHEMBL1443384 CHEMBL1446902 CHEMBL1515083 |
D013755
|
57 / 57 / 76 | 471 / 23 | No. 2113 |
|
|
C00003487
|
Crotonkinin A
|
CHEMBL399742
|
No. 2113 |
|
|||
|
C00048066
|
Phorbol 12-tiglate 13-decanoate
|
C011986
|
No. 2113 |
|
|||
|
C00049031
|
Triptolide
|
CHEMBL463763
CHEMBL444360 |
C001899
|
6 / 13 / 18 | 20 / 15 | No. 2113 |
|
|
C00003469
|
Pterokaurane M2
/ (-)-Pterokaurane M2 |
CHEMBL255516
|
No. 2113 |
|
|||
|
C00022158
|
GA100
/ Gibberellin A100 |
No. 3035 |
|
||||
|
C00022159
|
GA102
/ Gibberellin A102 |
No. 3035 |
|
||||
|
C00003457
|
Episinfernol
|
No. 3035 |
|
||||
|
C00003495
|
Oryzalexin S
|
No. 3035 |
|
||||
|
C00003440
|
Glabcensin Y
/ (-)-Glabcensin Y |
No. 3185 |
|
||||
|
C00030595
|
Isodonoiol
/ Rabdosin C / Rabdophyllin G |
CHEMBL452862
|
C037511
|
No. 3185 |
|
||
|
C00030594
|
Trichorabdal A
|
C090066
|
No. 3185 |
|
|||
|
C00003494
|
ent-Pimar-15-ene-8alpha,19-diol
|
CHEMBL518510
CHEMBL1094092 |
No. 3698 |
|
|||
|
C00034731
|
Xindongnin B
/ (-)-Xindongnin B |
No. 3698 |
|
||||
|
C00003493
|
ent-15-oxokaur-16-en-18-oic acid
|
CHEMBL252316
CHEMBL598599 CHEMBL2337572 |
No. 3698 |
|
|||
|
C00045577
|
Rebaudioside D
|
No. 3700 |
|
||||
|
C00049380
|
Tinyatoxin
|
C026001
|
No. 3700 |
|
|||
|
C00003439
|
Melissoidesin F
/ (+)-Melissoidesin F |
CHEMBL457827
|
No. 3700 |
|
|||
|
C00022027
|
GA125
/ Gibberellin A125 |
No. 3772 |
|
||||
|
C00003453
|
Candicandiol
|
CHEMBL561846
|
2 / 1 / 0 | No. 3772 |
|
||
|
C00042216
|
Euphornin
|
CHEMBL499921
|
No. 3772 |
|
|||
|
C00000279
|
Lungshengenin G
/ (-)-Lungshengenin G |
No. 4689 |
|
||||
|
C00003441
|
Leucophyllin C
/ (+)-Leucophyllin C |
No. 4689 |
|
||||
|
C00003478
|
Candol B
/ Ent-18-Hydroxykaur-16-ene |
CHEMBL512447
CHEMBL590263 |
No. 4826 |
|
|||
|
C00003492
|
ent-Beyer-15-en-19-ol
|
CHEMBL1979559
|
No. 4826 |
|
|||
|
C00003450
|
ent-15alpha,18-Dihydroxykaur-16-ene
|
No. 4968 |
|
||||
|
C00047942
|
Diterpenoid EF-D
|
CHEMBL520853
|
No. 4968 |
|
|||
|
C00003477
|
ent-Kaurene
/ ent-Kaur-16-ene / (-)-ent-Kaur-16-ene |
CHEMBL454740
|
No. 4995 |
|
|||
|
C00003465
|
Doianoterpene C
/ (-)-Doianoterpene C |
No. 4995 |
|
||||
|
C00003420
|
Taibairubescensin A
|
No. 5420 |
|
||||
|
C00038110
|
Wikstroelide B
/ (+)-Wikstroelide B |
No. 5420 |
|
||||
|
C00003448
|
Pterokaurane M1
/ (-)-Pterokaurane M1 |
CHEMBL255515
|
No. 5430 |
|
|||
|
C00046056
|
Ponalactone A
|
No. 5430 |
|
||||
|
C00003484
|
ent-11alpha-Hydroxy-16-kauren-15-one
/ ent-11alpha-Hydroxy-16R-kauran-15-one |
No. 5654 |
|
||||
|
C00045788
|
Podolactone E
|
CHEMBL521309
|
C008945
|
No. 5654 |
|
||
|
C00003405
|
Melissoidesin O
/ (-)-Melissoidesin O |
CHEMBL463554
|
No. 5835 |
|
|||
|
C00003409
|
Adenanthin I
/ (-)-Adenanthin I |
No. 6255 |
|
||||
|
C00003436
|
Melissoidesin T
/ (+)-Melissoidesin T |
CHEMBL517762
|
No. 6514 |
|
|||
|
C00003403
|
Taibairubescensin B
|
No. 6940 |
|
||||
|
C00003407
|
Glabcensin I
/ (-)-Glabcensin I |
No. 8155 |
|
||||
|
C00003475
|
Sidendrodiol
|
No. 8400 |
|
| accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|
| P83916 | Chromobox protein homolog 1 | Unclassified protein | C00000003 C00000268 C00003405 C00003416 C00003485 C00003491 C00022388 C00022389 | 0 / 0 |
| P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00000268 C00000269 C00003416 C00003452 C00003454 C00022388 C00022389 | 0 / 0 |
| Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00000268 C00000269 C00003416 C00003452 C00003454 C00003491 | 0 / 0 |
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00000003 C00003405 C00003416 C00003491 C00036880 | 0 / 1 |
| P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00003454 C00022388 C00022389 C00029401 C00049984 | 7 / 3 |
| Q9UNA4 | DNA polymerase iota | Enzyme | C00000268 C00003491 C00029401 C00034695 C00049984 | 0 / 0 |
| P22303 | Acetylcholinesterase | Hydrolase | C00003405 C00034462 C00034463 C00035512 C00047231 | 1 / 0 |
| Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00000268 C00000269 C00003405 C00003416 C00003454 | 0 / 0 |
| O75496 | Geminin | Unclassified protein | C00000003 C00000268 C00000269 C00003416 C00003491 | 0 / 0 |
| Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00003416 C00003452 C00003491 C00034695 C00036880 | 0 / 0 |
| P02545 | Prelamin-A/C | Unclassified protein | C00000003 C00000268 C00000269 C00003491 C00003494 | 11 / 10 |
| P06276 | Cholinesterase | Hydrolase | C00034462 C00034463 C00035512 C00047231 | 0 / 0 |
| Q99700 | Ataxin-2 | Unclassified protein | C00000268 C00000269 C00003454 C00003491 | 1 / 1 |
| P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00000003 C00003405 C00003416 C00003491 | 0 / 1 |
| Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00003407 C00003416 C00003491 C00036880 | 1 / 2 |
| P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00000003 C00003405 C00003416 C00003491 | 1 / 1 |
| Q16637 | Survival motor neuron protein | Unclassified protein | C00000268 C00000269 C00003416 C00003491 | 4 / 1 |
| Q12791 | Calcium-activated potassium channel subunit alpha-1 | KCNM, KCa1.x | C00003474 C00030622 C00035978 C00046986 | 1 / 1 |
| P17252 | Protein kinase C alpha type | Alpha | C00003405 C00003439 C00003491 C00040076 | 0 / 0 |
| P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00003454 C00003491 C00029401 C00049984 | 0 / 0 |
| P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00000003 C00000268 C00000269 C00034695 | 2 / 0 |
| P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00000003 C00003405 C00003416 C00003491 | 0 / 0 |
| P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00000003 C00003405 C00003416 C00003491 | 1 / 0 |
| Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00003454 C00003491 C00036880 | 1 / 1 |
| P51151 | Ras-related protein Rab-9A | Unclassified protein | C00000269 C00003491 C00003494 | 0 / 0 |
| P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | C00000881 C00037368 C00049686 | 0 / 0 |
| Q9Y253 | DNA polymerase eta | Enzyme | C00003491 C00029401 C00049984 | 1 / 1 |
| P37840 | Alpha-synuclein | Unclassified protein | C00003454 C00022388 C00022389 | 4 / 2 |
| Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00000269 C00029401 C00049984 | 0 / 0 |
| P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00003474 C00003485 C00003491 | 2 / 0 |
| P04150 | Glucocorticoid receptor | NR3C1 | C00003405 C00003485 C00034695 | 0 / 1 |
| P21728 | D(1A) dopamine receptor | Dopamine receptor | C00003405 C00003416 C00003491 | 0 / 0 |
| P28482 | Mitogen-activated protein kinase 1 | Erk | C00003405 C00003416 C00036880 | 0 / 0 |
| O15118 | Niemann-Pick C1 protein | Unclassified protein | C00000269 C00003491 C00003494 | 1 / 1 |
| P10636 | Microtubule-associated protein tau | Unclassified protein | C00003405 C00003491 C00036880 | 4 / 3 |
| O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | C00000268 C00000269 C00003454 | 1 / 0 |
| Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00003452 C00003491 C00003494 | 1 / 4 |
| Q13951 | Core-binding factor subunit beta | Unclassified protein | C00003452 C00003491 C00003494 | 0 / 1 |
| O00255 | Menin | Unclassified protein | C00003407 C00003491 C00036880 | 2 / 5 |
| P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | C00000269 C00003416 C00003491 | 0 / 0 |
| P06746 | DNA polymerase beta | Enzyme | C00000268 C00029401 C00049984 | 0 / 0 |
| P54132 | Bloom syndrome protein | Enzyme | C00003416 C00003491 | 1 / 2 |
| P05771 | Protein kinase C beta type | Alpha | C00003491 C00040076 | 0 / 0 |
| Q02156 | Protein kinase C epsilon type | Eta | C00003491 C00040076 | 0 / 0 |
| Q8IUX4 | DNA dC->dU-editing enzyme APOBEC-3F | Enzyme | C00000269 C00003454 | 0 / 0 |
| P03372 | Estrogen receptor | NR3A1 | C00003405 C00003416 | 1 / 1 |
| Q6W5P4 | Neuropeptide S receptor | Neuropeptide receptor | C00003416 C00003491 | 1 / 0 |
| P08183 | Multidrug resistance protein 1 | drug | C00003416 C00047942 | 1 / 0 |
| O94806 | Serine/threonine-protein kinase D3 | Pkd | C00003491 C00040076 | 0 / 0 |
| Q01453 | Peripheral myelin protein 22 | Unclassified protein | C00003416 C00003491 | 5 / 2 |
| Q05655 | Protein kinase C delta type | Delta | C00003491 C00040076 | 0 / 0 |
| Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00003491 C00036880 | 3 / 3 |
| Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00003405 C00003491 | 2 / 2 |
| P25021 | Histamine H2 receptor | Histamine receptor | C00003405 C00022217 | 0 / 0 |
| P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00003405 C00003494 | 0 / 3 |
| Q07817 | Bcl-2-like protein 1 | Other cytosolic protein | C00037922 C00037923 | 0 / 0 |
| P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00003405 C00022217 | 1 / 0 |
| Q9GZV3 | High affinity choline transporter 1 | Choline Na-symporter | C00022388 C00022389 | 1 / 0 |
| O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00003405 C00003491 | 0 / 0 |
| P11021 | 78 kDa glucose-regulated protein | Unclassified protein | C00003454 C00003491 | 0 / 0 |
| Q9UBT6 | DNA polymerase kappa | Enzyme | C00003416 C00003491 | 0 / 0 |
| P16473 | Thyrotropin receptor | Glycohormone receptor | C00003416 C00003491 | 3 / 2 |
| Q04759 | Protein kinase C theta type | Delta | C00003491 C00040076 | 0 / 1 |
| P00352 | Retinal dehydrogenase 1 | Enzyme | C00003491 C00036880 | 0 / 0 |
| P04637 | Cellular tumor antigen p53 | Transcription Factor | C00003491 C00036880 | 7 / 37 |
| O75604 | Ubiquitin carboxyl-terminal hydrolase 2 | Enzyme | C00003491 C00036880 | 0 / 0 |
| Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00003416 C00003491 | 0 / 0 |
| P42858 | Huntingtin | Unclassified protein | C00000268 C00000269 | 1 / 1 |
| P24723 | Protein kinase C eta type | Eta | C00003491 C00040076 | 1 / 0 |
| Q15139 | Serine/threonine-protein kinase D1 | Pkd | C00003491 C00040076 | 0 / 0 |
| B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00003491 C00036880 | 0 / 0 |
| P05129 | Protein kinase C gamma type | Alpha | C00003491 C00040076 | 1 / 1 |
| Q99549 | M-phase phosphoprotein 8 | Unclassified protein | C00003491 | 0 / 0 |
| P16233 | Pancreatic triacylglycerol lipase | Hydrolase | C00036880 | 0 / 0 |
| P21917 | D(4) dopamine receptor | Dopamine receptor | C00003405 | 0 / 0 |
| P30988 | Calcitonin receptor | Calcitonin receptor | C00003405 | 0 / 0 |
| P35462 | D(3) dopamine receptor | Dopamine receptor | C00003405 | 1 / 0 |
| P41143 | Delta-type opioid receptor | Opioid receptor | C00003405 | 0 / 0 |
| Q92731 | Estrogen receptor beta | NR3A2 | C00003405 | 0 / 1 |
| P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00003405 | 0 / 0 |
| P25101 | Endothelin-1 receptor | Endothelin receptor | C00003405 | 0 / 0 |
| P30411 | B2 bradykinin receptor | Bradykinin receptor | C00003405 | 0 / 0 |
| P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00003405 | 1 / 0 |
| P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00003405 | 0 / 0 |
| P08311 | Cathepsin G | S1A | C00003405 | 0 / 0 |
| Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00003405 | 1 / 0 |
| P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00003405 | 0 / 0 |
| P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00003405 | 0 / 0 |
| P03956 | Interstitial collagenase | M10A | C00003405 | 0 / 1 |
| P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00003405 | 0 / 0 |
| P17405 | Sphingomyelin phosphodiesterase | Enzyme | C00003454 | 2 / 2 |
| P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00003405 | 1 / 0 |
| P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00003405 | 0 / 0 |
| O15296 | Arachidonate 15-lipoxygenase B | Enzyme | C00036880 | 0 / 0 |
| P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00003405 | 1 / 1 |
| P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00003405 | 0 / 0 |
| P51843 | Nuclear receptor subfamily 0 group B member 1 | Nuclear hormone receptor subfamily 0 group B member 1 | C00003416 | 2 / 2 |
| P29274 | Adenosine receptor A2a | Adenosine receptor | C00003405 | 0 / 0 |
| P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00003405 | 2 / 0 |
| P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00003405 | 0 / 0 |
| P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00003405 | 0 / 0 |
| P31645 | Sodium-dependent serotonin transporter | Serotonin | C00003405 | 2 / 0 |
| P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | C00003416 | 5 / 3 |
| P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00003405 | 5 / 9 |
| Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00003405 | 0 / 0 |
| P21452 | Substance-K receptor | Neurokinin receptor | C00003405 | 0 / 0 |
| P41145 | Kappa-type opioid receptor | Opioid receptor | C00003405 | 0 / 0 |
| P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00003405 | 0 / 0 |
| P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00003405 | 3 / 0 |
| P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00003405 | 0 / 0 |
| P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00003405 | 0 / 0 |
| P18054 | Arachidonate 12-lipoxygenase, 12S-type | Enzyme | C00036880 | 2 / 0 |
| Q13133 | Oxysterols receptor LXR-alpha | NR1H3 | C00003474 | 0 / 0 |
| P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00003405 | 1 / 0 |
| P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00003405 | 0 / 0 |
| P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00003405 | 2 / 1 |
| P14416 | D(2) dopamine receptor | Dopamine receptor | C00003405 | 2 / 0 |
| P55055 | Oxysterols receptor LXR-beta | NR1H3 | C00003474 | 0 / 0 |
| P11473 | Vitamin D3 receptor | NR1I1 | C00036880 | 2 / 3 |
| P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00036880 | 2 / 2 |
| P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00003405 | 1 / 8 |
| Q9NR56 | Muscleblind-like protein 1 | Unclassified protein | C00000269 | 1 / 0 |
| Q8WXD0 | Relaxin receptor 2 | Relaxin receptor | C00003416 | 1 / 1 |
| O75030 | Microphthalmia-associated transcription factor | Unclassified protein | C00000269 | 4 / 4 |
| Q9HBX9 | Relaxin receptor 1 | Relaxin receptor | C00003416 | 0 / 0 |
| O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00003405 | 0 / 0 |
| Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00003405 | 0 / 0 |
| P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00003405 | 1 / 0 |
| Q08828 | Adenylate cyclase type 1 | Enzyme | C00003416 | 0 / 0 |
| P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00003405 | 0 / 0 |
| P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00003405 | 0 / 0 |
| P35372 | Mu-type opioid receptor | Opioid receptor | C00003405 | 0 / 0 |
| P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00003405 | 0 / 0 |
| P25103 | Substance-P receptor | Neurokinin receptor | C00003405 | 0 / 0 |
| P25105 | Platelet-activating factor receptor | PAF receptor | C00003405 | 0 / 0 |
| P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00003405 | 0 / 0 |
| P06241 | Tyrosine-protein kinase Fyn | Src | C00003405 | 0 / 0 |
| P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00003405 | 0 / 0 |
| Q8WUI4 | Histone deacetylase 7 | Hydrolase | C00003416 | 0 / 0 |
| P11166 | Solute carrier family 2, facilitated glucose transporter member 1 | Glucose uniporter | C00003416 | 4 / 2 |
| P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00003405 | 0 / 0 |
| P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00003405 | 0 / 0 |
| Q8IV61 | Ras guanyl-releasing protein 3 | Other cytosolic protein | C00003491 | 0 / 0 |
| P21918 | D(1B) dopamine receptor | Dopamine receptor | C00022217 | 1 / 0 |
| P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00003405 | 0 / 0 |
| O75164 | Lysine-specific demethylase 4A | Enzyme | C00003454 | 0 / 0 |
| P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00003405 | 0 / 0 |
| Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00003405 | 1 / 0 |
| P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00003405 | 0 / 0 |
| P35367 | Histamine H1 receptor | Histamine receptor | C00003405 | 0 / 0 |
| P08908 | 5-hydroxytryptamine receptor 1A | Serotonin receptor | C00003416 | 1 / 0 |
| P10275 | Androgen receptor | NR3C4 | C00000003 | 3 / 4 |
| P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00003405 | 1 / 1 |
| P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00003405 | 0 / 0 |
| P30542 | Adenosine receptor A1 | Adenosine receptor | C00003405 | 0 / 0 |
| P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00003405 | 0 / 0 |
| P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00003405 | 1 / 1 |
| P05412 | Transcription factor AP-1 | Transcription Factor | C00000273 | 0 / 0 |
| P06239 | Tyrosine-protein kinase Lck | Src | C00003405 | 0 / 1 |
| P35869 | Aryl hydrocarbon receptor | Transcription Factor | C00003416 | 0 / 0 |
| P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00003405 | 0 / 0 |
| P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00003405 | 1 / 1 |
| P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00003405 | 0 / 1 |
| P00918 | Carbonic anhydrase 2 | Lyase | C00003405 | 1 / 2 |
| Q8TDU6 | G-protein coupled bile acid receptor 1 | Steroid-like ligand receptor | C00003416 | 0 / 0 |
| P40225 | Thrombopoietin | Unclassified protein | C00003491 | 1 / 1 |
| O00167 | Eyes absent homolog 2 | Enzyme | C00003491 | 0 / 0 |
| Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00003405 | 0 / 0 |
| O95267 | RAS guanyl-releasing protein 1 | Unclassified protein | C00003491 | 1 / 0 |
| P14780 | Matrix metalloproteinase-9 | M10A | C00003405 | 2 / 2 |
| P27361 | Mitogen-activated protein kinase 3 | Erk | C00003405 | 0 / 0 |
| P29466 | Caspase-1 | C14 | C00003405 | 0 / 0 |
| P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00003405 | 0 / 0 |
| Q16539 | Mitogen-activated protein kinase 14 | p38 | C00003405 | 0 / 0 |
| P33765 | Adenosine receptor A3 | Adenosine receptor | C00003405 | 0 / 0 |
| Q05513 | Protein kinase C zeta type | Iota | C00003491 | 0 / 0 |
| P08246 | Neutrophil elastase | S1A | C00003405 | 2 / 1 |
| P13569 | Cystic fibrosis transmembrane conductance regulator | chloride | C00003416 | 2 / 3 |
| P41743 | Protein kinase C iota type | Iota | C00003491 | 0 / 0 |
| P42345 | Serine/threonine-protein kinase mTOR | Enzyme | C00003491 | 0 / 0 |
| O60266 | Adenylate cyclase type 3 | Enzyme | C00003416 | 0 / 0 |
| O43306 | Adenylate cyclase type 6 | Enzyme | C00003416 | 0 / 0 |
| Q08462 | Adenylate cyclase type 2 | Enzyme | C00003416 | 0 / 0 |
| O60503 | Adenylate cyclase type 9 | Enzyme | C00003416 | 0 / 0 |
| P51828 | Adenylate cyclase type 7 | Enzyme | C00003416 | 0 / 0 |
| P40145 | Adenylate cyclase type 8 | Enzyme | C00003416 | 0 / 0 |
| O95622 | Adenylate cyclase type 5 | Enzyme | C00003416 | 1 / 0 |
| Q8NFM4 | Adenylate cyclase type 4 | Enzyme | C00003416 | 0 / 0 |
| Q15118 | [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 1, mitochondrial | Pdhk | C00003474 | 0 / 0 |
| Q16654 | [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 4, mitochondrial | Pdhk | C00003474 | 0 / 0 |
| Q15119 | [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 2, mitochondrial | Pdhk | C00003474 | 0 / 0 |
| Q15120 | [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 3, mitochondrial | Pdhk | C00003474 | 1 / 0 |
| Q00653 | Nuclear factor NF-kappa-B p100 subunit | Transcription Factor | C00000269 | 0 / 0 |
| Q04206 | Transcription factor p65 | Transcription Factor | C00000269 | 0 / 0 |
| Q9NY46 | Sodium channel protein type 3 subunit alpha | SCN alpha, NaV1.x | C00003416 | 0 / 0 |
| Q99250 | Sodium channel protein type 2 subunit alpha | SCN alpha, NaV1.x | C00003416 | 2 / 2 |
| P35498 | Sodium channel protein type 1 subunit alpha | SCN alpha, NaV1.x | C00003416 | 3 / 2 |
| P01215 | Glycoprotein hormones alpha chain | Unclassified protein | C00003454 | 0 / 3 |
| Q13148 | TAR DNA-binding protein 43 | Unclassified protein | C00034695 | 1 / 1 |
| gene | gene name | gene description | KNApSAcK metabolite in interactions |
|---|---|---|---|
| 836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00003407
C00003491
C00003494
|
| 5468 | PPARG, CIMT1, GLM1, NR1C3, PPARG1, PPARG2, PPARgamma | peroxisome proliferator-activated receptor gamma |
C00003440
C00003491
C00036880
|
| 142 | PARP1, ADPRT, ADPRT_1, ADPRT1, ARTD1, PARP, PARP-1, PPOL, pADPRT-1 | poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) |
C00003454
C00003491
C00003494
|
| 1432 | MAPK14, CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA | mitogen-activated protein kinase 14 (EC:2.7.11.24) |
C00003491
C00003494
|
| 596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00003407
C00003491
|
| 7442 | TRPV1, VR1 | transient receptor potential cation channel, subfamily V, member 1 |
C00003478
C00003491
|
| 1843 | DUSP1, CL100, HVH1, MKP-1, MKP1, PTPN10 | dual specificity phosphatase 1 (EC:3.1.3.16 3.1.3.48) |
C00003491
C00003494
|
| 5601 | MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, SAPK1a, p54a, p54aSAPK | mitogen-activated protein kinase 9 (EC:2.7.11.24) |
C00003478
C00003491
|
| 5599 | MAPK8, JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1, SAPK1c | mitogen-activated protein kinase 8 (EC:2.7.11.24) |
C00003478
C00003491
|
| 3383 | ICAM1, BB2, CD54, P3.58 | intercellular adhesion molecule 1 |
C00003491
C00003494
|
| 7421 | VDR, NR1I1 | vitamin D (1,25- dihydroxyvitamin D3) receptor |
C00003491
C00036880
|
| 3593 | IL12B, CLMF, CLMF2, IL-12B, NKSF, NKSF2 | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) |
C00003491
C00003494
|
| 3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00003491
C00003494
|
| 598 | BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, PPP1R52, bcl-xL, bcl-xS | BCL2-like 1 |
C00003407
C00003491
|
| 2908 | NR3C1, GCCR, GCR, GR, GRL | nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
C00003491
C00003494
|
| 54205 | CYCS, CYC, HCS, THC4 | cytochrome c, somatic |
C00003407
C00003491
|
| 6256 | RXRA, NR2B1 | retinoid X receptor, alpha |
C00003491
C00036880
|
| 5914 | RARA, NR1B1, RAR | retinoic acid receptor, alpha |
C00003491
C00036880
|
| 7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00003491
C00003494
|
| 929 | CD14 | CD14 molecule |
C00003491
C00036880
|
| 5578 | PRKCA, AAG6, PKC-alpha, PKCA, PRKACA | protein kinase C, alpha (EC:2.7.11.13) |
C00003454
C00003491
|
| 5579 | PRKCB, PKC-beta, PKCB, PRKCB1, PRKCB2 | protein kinase C, beta (EC:2.7.11.13) |
C00003454
C00003491
|
| 5582 | PRKCG, PKC-gamma, PKCC, PKCG, SCA14 | protein kinase C, gamma (EC:2.7.11.13) |
C00003454
C00003491
|
| 330 | BIRC3, AIP1, API2, CIAP2, HAIP1, HIAP1, MALT2, MIHC, RNF49, c-IAP2 | baculoviral IAP repeat containing 3 |
C00003491
C00003494
|
| 5587 | PRKD1, PKC-MU, PKCM, PKD, PRKCM | protein kinase D1 (EC:2.7.11.13) |
C00003440
C00003491
|
| 100136148 |
C00003491
C00036880
|
||
| 5054 | SERPINE1, PAI, PAI-1, PAI1, PLANH1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
C00003491
|
| 6863 | TAC1, Hs.2563, NK2, NKNA, NPK, TAC2 | tachykinin, precursor 1 |
C00003494
|
| 6839 | SUV39H1, H3-K9-HMTase_1, KMT1A, MG44, SUV39H | suppressor of variegation 3-9 homolog 1 (Drosophila) (EC:2.1.1.43) |
C00003494
|
| 3592 | IL12A, CLMF, IL-12A, NFSK, NKSF1, P35 | interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) |
C00003494
|
| 3303 | HSPA1A, HSP70-1, HSP70-1A, HSP70I, HSP72, HSPA1 | heat shock 70kDa protein 1A |
C00003494
|
| 2146 | EZH2, ENX-1, ENX1, EZH1, EZH2b, KMT6, KMT6A, WVS, WVS2 | enhancer of zeste homolog 2 (Drosophila) (EC:2.1.1.43) |
C00003494
|
| 1082 | CGB, CGB3, CGB5, CGB7, CGB8, hCGB | chorionic gonadotropin, beta polypeptide |
C00003494
|
| 942 | CD86, B7-2, B7.2, B70, CD28LG2, LAB72 | CD86 molecule |
C00003494
|
| 941 | CD80, B7, B7-1, B7.1, BB1, CD28LG, CD28LG1, LAB7 | CD80 molecule |
C00003494
|
| 8837 | CFLAR, CASH, CASP8AP1, CLARP, Casper, FLAME, FLAME-1, FLAME1, FLIP, I-FLICE, MRIT, c-FLIP, c-FLIPL, c-FLIPR, c-FLIPS | CASP8 and FADD-like apoptosis regulator |
C00003407
|
| 840 | CASP7, CASP-7, CMH-1, ICE-LAP3, LICE2, MCH3 | caspase 7, apoptosis-related cysteine peptidase (EC:3.4.22.60) |
C00003494
|
| 2944 | GSTM1, GST1, GSTM1-1, GSTM1a-1a, GSTM1b-1b, GTH4, GTM1, H-B, MU, MU-1 | glutathione S-transferase mu 1 (EC:2.5.1.18) |
C00003407
|
| 4170 | MCL1, BCL2L3, EAT, MCL1-ES, MCL1L, MCL1S, Mcl-1, TM, bcl2-L-3, mcl1/EAT | myeloid cell leukemia sequence 1 (BCL2-related) |
C00003407
|
| 6817 | SULT1A1, HAST1/HAST2, P-PST, PST, ST1A1, ST1A3, STP, STP1, TSPST1 | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 (EC:2.8.2.1) |
C00003407
|
| 5244 | ABCB4, ABC21, GBD1, ICP3, MDR2, MDR2/3, MDR3, PFIC-3, PGY3 | ATP-binding cassette, sub-family B (MDR/TAP), member 4 (EC:3.6.3.44) |
C00003491
|
| 4363 | ABCC1, ABC29, ABCC, GS-X, MRP, MRP1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
C00003491
|
| 10257 | ABCC4, EST170205, MOAT-B, MOATB, MRP4 | ATP-binding cassette, sub-family C (CFTR/MRP), member 4 |
C00003491
|
| 1636 | ACE, ACE1, CD143, DCP, DCP1, ICH, MVCD3 | angiotensin I converting enzyme (EC:3.4.15.1) |
C00003491
|
| 60 | ACTB, BRWS1, PS1TP5BP1 | actin, beta |
C00003491
|
| 8038 | ADAM12, MCMP, MCMPMltna, MLTN, MLTNA | ADAM metallopeptidase domain 12 |
C00003491
|
| 101 | ADAM8, CD156, MS2 | ADAM metallopeptidase domain 8 (EC:3.4.24.-) |
C00003491
|
| 154 | ADRB2, ADRB2R, ADRBR, B2AR, BAR, BETA2AR | adrenoceptor beta 2, surface |
C00003491
|
| 196 | AHR, bHLHe76 | aryl hydrocarbon receptor |
C00003491
|
| 37815 |
C00003491
|
||
| 11199 | ANXA10, ANX14 | annexin A10 |
C00003491
|
| 306 | ANXA3, ANX3 | annexin A3 (EC:3.1.4.43) |
C00003491
|
| 317 | APAF1, APAF-1, CED4 | apoptotic peptidase activating factor 1 |
C00003491
|
| 27301 | APEX2, APE2, APEXL2, XTH2 | APEX nuclease (apurinic/apyrimidinic endonuclease) 2 (EC:4.2.99.18) |
C00003491
|
| 334 | APLP2, APLP-2, APPH, APPL2, CDEBP | amyloid beta (A4) precursor-like protein 2 |
C00003491
|
| 374 | AREG, AR, CRDGF, SDGF | amphiregulin |
C00003491
|
| 375 | ARF1 | ADP-ribosylation factor 1 |
C00003491
|
| 382 | ARF6 | ADP-ribosylation factor 6 |
C00003491
|
| 23229 | ARHGEF9, COLLYBISTIN, EIEE8, HPEM-2, PEM-2, PEM2 | Cdc42 guanine nucleotide exchange factor (GEF) 9 |
C00003491
|
| 10123 | ARL4C, ARL7, LAK | ADP-ribosylation factor-like 4C |
C00003491
|
| 10550 | ARL6IP5, DERP11, GTRAP3-18, JWA, PRAF3, addicsin, hp22, jmx | ADP-ribosylation-like factor 6 interacting protein 5 |
C00003491
|
| 10109 | ARPC2, ARC34, PNAS-139, p34-Arc | actin related protein 2/3 complex, subunit 2, 34kDa |
C00003491
|
| 445 | ASS1, ASS, CTLN1 | argininosuccinate synthase 1 (EC:6.3.4.5) |
C00003491
|
| 468 | ATF4, CREB-2, CREB2, TAXREB67, TXREB | activating transcription factor 4 |
C00003491
|
| 22809 | ATF5, ATFX, HMFN0395 | activating transcription factor 5 |
C00003491
|
| 538 | ATP7A, DSMAX, MK, MNK, SMAX3 | ATPase, Cu++ transporting, alpha polypeptide (EC:3.6.3.54) |
C00003491
|
| 540 | ATP7B, PWD, WC1, WD, WND | ATPase, Cu++ transporting, beta polypeptide (EC:3.6.3.54) |
C00003491
|
| 6790 | AURKA, AIK, ARK1, AURA, AURORA2, BTAK, PPP1R47, STK15, STK6, STK7 | aurora kinase A (EC:2.7.11.1) |
C00003491
|
| 573 | BAG1, BAG-1, HAP, RAP46 | BCL2-associated athanogene |
C00003491
|
| 578 | BAK1, BAK, BAK-LIKE, BCL2L7, CDN1 | BCL2-antagonist/killer 1 |
C00003491
|
| 581 | BAX, BCL2L4 | BCL2-associated X protein |
C00003491
|
| 597 | BCL2A1, ACC-1, ACC-2, BCL2L5, BFL1, GRS, HBPA1 | BCL2-related protein A1 |
C00003491
|
| 329 | BIRC2, API1, HIAP2, Hiap-2, MIHB, RNF48, c-IAP1, cIAP1 | baculoviral IAP repeat containing 2 |
C00003491
|
| 332 | BIRC5, API4, EPR-1 | baculoviral IAP repeat containing 5 |
C00003491
|
| 650 | BMP2, BDA2, BMP2A | bone morphogenetic protein 2 |
C00003491
|
| 682 | BSG, 5F7, CD147, EMMPRIN, M6, OK, TCSF | basigin |
C00003491
|
| 7832 | BTG2, PC3, TIS21 | BTG family, member 2 |
C00003491
|
| 701 | BUB1B, BUB1beta, BUBR1, Bub1A, MAD3L, MVA1, SSK1, hBUBR1 | BUB1 mitotic checkpoint serine/threonine kinase B (EC:2.7.11.1) |
C00003491
|
| 23632 | CA14, CAXiV | carbonic anhydrase XIV (EC:4.2.1.1) |
C00003491
|
| 811 | CALR, CRT, RO, SSA, cC1qR | calreticulin |
C00003491
|
| 8536 | CAMK1, CAMKI | calcium/calmodulin-dependent protein kinase I (EC:2.7.11.17) |
C00003491
|
| 11131 | CAPN11, calpain11 | calpain 11 |
C00003491
|
| 10753 | CAPN9, GC36, nCL-4 | calpain 9 (EC:3.4.22.-) |
C00003491
|
| 834 | CASP1, ICE, IL1BC, P45 | caspase 1, apoptosis-related cysteine peptidase (EC:3.4.22.36) |
C00003491
|
| 100506742 | CASP12, CASP-12, CASP12P1 | caspase 12 (gene/pseudogene) |
C00003491
|
| 841 | CASP8, ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5 | caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) |
C00003491
|
| 842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) |
C00003491
|
| 847 | CAT | catalase (EC:1.11.1.6) |
C00003491
|
| 6346 | CCL1, I-309, P500, SCYA1, SISe, TCA3 | chemokine (C-C motif) ligand 1 |
C00003491
|
| 6356 | CCL11, SCYA11 | chemokine (C-C motif) ligand 11 |
C00003491
|
| 6362 | CCL18, AMAC-1, AMAC1, CKb7, DC-CK1, DCCK1, MIP-4, PARC, SCYA18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) |
C00003491
|
| 6347 | CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, SCYA2, SMC-CF | chemokine (C-C motif) ligand 2 |
C00003491
|
| 6348 | CCL3, G0S19-1, LD78ALPHA, MIP-1-alpha, MIP1A, SCYA3 | chemokine (C-C motif) ligand 3 |
C00003491
|
| 6349 | CCL3L1, 464.2, D17S1718, G0S19-2, LD78, LD78BETA, MIP1AP, SCYA3L, SCYA3L1 | chemokine (C-C motif) ligand 3-like 1 |
C00003491
|
| 6351 | CCL4, ACT2, AT744.1, G-26, HC21, LAG-1, LAG1, MIP-1-beta, MIP1B, MIP1B1, SCYA2, SCYA4 | chemokine (C-C motif) ligand 4 |
C00003491
|
| 9560 | CCL4L1, AT744.2, CCL4L, LAG-1, LAG1, SCYA4L | chemokine (C-C motif) ligand 4-like 1 |
C00003491
|
| 6352 | CCL5, D17S136E, RANTES, SCYA5, SIS-delta, SISd, TCP228, eoCP | chemokine (C-C motif) ligand 5 |
C00003491
|
| 890 | CCNA2, CCN1, CCNA | cyclin A2 |
C00003491
|
| 9133 | CCNB2, HsT17299 | cyclin B2 |
C00003491
|
| 595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 |
C00003491
|
| 896 | CCND3 | cyclin D3 |
C00003491
|
| 898 | CCNE1, CCNE | cyclin E1 |
C00003491
|
| 900 | CCNG1, CCNG | cyclin G1 |
C00003491
|
| 22948 | CCT5, CCT-epsilon, CCTE, TCP-1-epsilon | chaperonin containing TCP1, subunit 5 (epsilon) |
C00003491
|
| 4345 | CD200, MOX1, MOX2, MRC, OX-2 | CD200 molecule |
C00003491
|
| 940 | CD28, Tp44 | CD28 molecule |
C00003491
|
| 947 | CD34 | CD34 molecule |
C00003491
|
| 948 | CD36, BDPLT10, CHDS7, FAT, GP3B, GP4, GPIV, PASIV, SCARB3 | CD36 molecule (thrombospondin receptor) |
C00003491
|
| 920 | CD4, CD4mut | CD4 molecule |
C00003491
|
| 958 | CD40, Bp50, CDW40, TNFRSF5, p50 | CD40 molecule, TNF receptor superfamily member 5 |
C00003491
|
| 959 | CD40LG, CD154, CD40L, HIGM1, IGM, IMD3, T-BAM, TNFSF5, TRAP, gp39, hCD40L | CD40 ligand |
C00003491
|
| 960 | CD44, CDW44, CSPG8, ECMR-III, HCELL, HUTCH-I, IN, LHR, MC56, MDU2, MDU3, MIC4, Pgp1 | CD44 molecule (Indian blood group) |
C00003491
|
| 965 | CD58, LFA-3, LFA3, ag3 | CD58 molecule |
C00003491
|
| 969 | CD69, AIM, BL-AC/P26, CLEC2C, EA1, GP32/28, MLR-3 | CD69 molecule |
C00003491
|
| 928 | CD9, BTCC-1, DRAP-27, MIC3, MRP-1, TSPAN-29, TSPAN29 | CD9 molecule |
C00003491
|
| 991 | CDC20, CDC20A, bA276H19.3, p55CDC | cell division cycle 20 |
C00003491
|
| 994 | CDC25B | cell division cycle 25B (EC:3.1.3.48) |
C00003491
|
| 995 | CDC25C, CDC25, PPP1R60 | cell division cycle 25C (EC:3.1.3.48) |
C00003491
|
| 1015 | CDH17, CDH16, HPT-1, HPT1 | cadherin 17, LI cadherin (liver-intestine) |
C00003491
|
| 1017 | CDK2, p33(CDK2) | cyclin-dependent kinase 2 (EC:2.7.11.22) |
C00003491
|
| 1019 | CDK4, CMM3, PSK-J3 | cyclin-dependent kinase 4 (EC:2.7.11.22) |
C00003491
|
| 1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00003491
|
| 1027 | CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27KIP1 | cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
C00003491
|
| 1028 | CDKN1C, BWCR, BWS, KIP2, WBS, p57, p57Kip2 | cyclin-dependent kinase inhibitor 1C (p57, Kip2) |
C00003491
|
| 1029 | CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4A, MLM, MTS-1, MTS1, P14, P14ARF, P16, P16-INK4A, P16INK4, P16INK4A, P19, P19ARF, TP16 | cyclin-dependent kinase inhibitor 2A |
C00003491
|
| 1030 | CDKN2B, CDK4I, INK4B, MTS2, P15, TP15, p15INK4b | cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
C00003491
|
| 1031 | CDKN2C, INK4C, p18, p18-INK4C | cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) |
C00003491
|
| 1147 | CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16 | conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10) |
C00003491
|
| 1164 | CKS2, CKSHS2 | CDC28 protein kinase regulatory subunit 2 |
C00003491
|
| 1364 | CLDN4, CPE-R, CPER, CPETR, CPETR1, WBSCR8, hCPE-R | claudin 4 |
C00003491
|
| 1201 | CLN3, BTS, JNCL | ceroid-lipofuscinosis, neuronal 3 |
C00003491
|
| 8418 | CMAHP, CMAH, CSAH | cytidine monophospho-N-acetylneuraminic acid hydroxylase, pseudogene |
C00003491
|
| 1240 | CMKLR1, CHEMERINR, ChemR23, DEZ, RVER1 | chemokine-like receptor 1 |
C00003491
|
| 1264 | CNN1, SMCC, Sm-Calp | calponin 1, basic, smooth muscle |
C00003491
|
| 27255 | CNTN6, NB3 | contactin 6 |
C00003491
|
| 1278 | COL1A2, OI4 | collagen, type I, alpha 2 |
C00003491
|
| 1291 | COL6A1, OPLL | collagen, type VI, alpha 1 |
C00003491
|
| 1312 | COMT | catechol-O-methyltransferase (EC:2.1.1.6) |
C00003491
|
| 4513 | COX2, COII, MTCO2, MT-CO2 | cytochrome c oxidase subunit II |
C00003491
|
| 1385 | CREB1, CREB | cAMP responsive element binding protein 1 |
C00003491
|
| 1387 | CREBBP, CBP, KAT3A, RSTS | CREB binding protein (EC:2.3.1.48) |
C00003491
|
| 1390 | CREM, CREM-2, ICER, hCREM-2 | cAMP responsive element modulator |
C00003491
|
| 56253 | CRTAM, CD355 | cytotoxic and regulatory T cell molecule |
C00003491
|
| 1407 | CRY1, PHLL1 | cryptochrome 1 (photolyase-like) |
C00003491
|
| 1437 | CSF2, GMCSF | colony stimulating factor 2 (granulocyte-macrophage) |
C00003491
|
| 1440 | CSF3, C17orf33, CSF3OS, GCSF, G-CSF | colony stimulating factor 3 (granulocyte) |
C00003491
|
| 1487 | CTBP1, BARS | C-terminal binding protein 1 |
C00003491
|
| 8065 | CUL5, VACM-1, VACM1 | cullin 5 |
C00003491
|
| 6376 | CX3CL1, ABCD-3, C3Xkine, CXC3, CXC3C, NTN, NTT, SCYD1, fractalkine, neurotactin | chemokine (C-X3-C motif) ligand 1 |
C00003491
|
| 6387 | CXCL12, IRH, PBSF, SCYB12, SDF1, TLSF, TPAR1, SDF1A, SDF1B | chemokine (C-X-C motif) ligand 12 |
C00003491
|
| 6374 | CXCL5, ENA-78, SCYB5 | chemokine (C-X-C motif) ligand 5 |
C00003491
|
| 6372 | CXCL6, CKA-3, GCP-2, GCP2, SCYB6 | chemokine (C-X-C motif) ligand 6 |
C00003491
|
| 3577 | CXCR1, C-C, C-C-CKR-1, CD128, CD181, CDw128a, CKR-1, CMKAR1, IL8R1, IL8RA, IL8RBA | chemokine (C-X-C motif) receptor 1 |
C00003491
|
| 3579 | CXCR2, CD182, CDw128b, CMKAR2, IL8R2, IL8RA, IL8RB | chemokine (C-X-C motif) receptor 2 |
C00003491
|
| 1535 | CYBA, p22-PHOX | cytochrome b-245, alpha polypeptide |
C00003491
|
| 1536 | CYBB, AMCBX2, CGD, GP91-1, GP91-PHOX, GP91PHOX, NOX2, p91-PHOX | cytochrome b-245, beta polypeptide |
C00003491
|
| 1585 | CYP11B2, ALDOS, CPN2, CYP11B, CYP11BL, CYPXIB2, P-450C18, P450C18, P450aldo | cytochrome P450, family 11, subfamily B, polypeptide 2 (EC:1.14.15.4 1.14.15.5) |
C00003491
|
| 1588 | CYP19A1, ARO, ARO1, CPV1, CYAR, CYP19, CYPXIX, P-450AROM | cytochrome P450, family 19, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00003491
|
| 1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00003491
|
| 1544 | CYP1A2, CP12, P3-450, P450(PA) | cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) |
C00003491
|
| 1545 | CYP1B1, CP1B, CYPIB1, GLC3A, P4501B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) |
C00003491
|
| 1571 | CYP2E1, CPE1, CYP2E, P450-J, P450C2E | cytochrome P450, family 2, subfamily E, polypeptide 1 (EC:1.14.13.n7) |
C00003491
|
| 1581 | CYP7A1, CP7A, CYP7, CYPVII | cytochrome P450, family 7, subfamily A, polypeptide 1 (EC:1.14.13.17) |
C00003491
|
| 1612 | DAPK1, DAPK | death-associated protein kinase 1 (EC:2.7.11.1) |
C00003491
|
| 1638 | DCT, TRP-2, TYRP2 | dopachrome tautomerase (EC:5.3.3.12) |
C00003491
|
| 1735 | DIO3, 5DIII, D3, DIOIII, TXDI3 | deiodinase, iodothyronine, type III (EC:1.97.1.11) |
C00003491
|
| 8788 | DLK1, DLK, DLK-1, Delta1, FA1, PREF1, Pref-1, ZOG, pG2 | delta-like 1 homolog (Drosophila) |
C00003491
|
| 1806 | DPYD, DHP, DHPDHASE, DPD | dihydropyrimidine dehydrogenase (EC:1.3.1.2) |
C00003491
|
| 51207 | DUSP13, BEDP, DUSP13A, DUSP13B, MDSP, SKRP4, TMDP | dual specificity phosphatase 13 (EC:3.1.3.16 3.1.3.48) |
C00003491
|
| 1846 | DUSP4, HVH2, MKP-2, MKP2, TYP | dual specificity phosphatase 4 (EC:3.1.3.16 3.1.3.48) |
C00003491
|
| 1874 | E2F4, E2F-4 | E2F transcription factor 4, p107/p130-binding |
C00003491
|
| 8411 | EEA1, MST105, MSTP105, ZFYVE2 | early endosome antigen 1 |
C00003491
|
| 1945 | EFNA4, EFL4, EPLG4, LERK4 | ephrin-A4 |
C00003491
|
| 1950 | EGF, HOMG4, URG | epidermal growth factor |
C00003491
|
| 1956 | EGFR, ERBB, ERBB1, HER1, PIG61, mENA | epidermal growth factor receptor (EC:2.7.10.1) |
C00003491
|
| 1958 | EGR1, AT225, G0S30, KROX-24, NGFI-A, TIS8, ZIF-268, ZNF225 | early growth response 1 |
C00003491
|
| 1959 | EGR2, AT591, CMT1D, CMT4E, KROX20 | early growth response 2 |
C00003491
|
| 1961 | EGR4, NGFI-C, NGFIC, PAT133 | early growth response 4 |
C00003491
|
| 1977 | EIF4E, AUTS19, CBP, EIF4E1, EIF4EL1, EIF4F | eukaryotic translation initiation factor 4E |
C00003491
|
| 1978 | EIF4EBP1, 4E-BP1, 4EBP1, BP-1, PHAS-I | eukaryotic translation initiation factor 4E binding protein 1 |
C00003491
|
| 1981 | EIF4G1, EIF-4G1, EIF4F, EIF4G, EIF4GI, P220, PARK18 | eukaryotic translation initiation factor 4 gamma, 1 |
C00003491
|
| 1982 | EIF4G2, AAG1, DAP5, NAT1, P97 | eukaryotic translation initiation factor 4 gamma, 2 |
C00003491
|
| 1983 | EIF5, EIF-5, EIF-5A | eukaryotic translation initiation factor 5 |
C00003491
|
| 2002 | ELK1 | ELK1, member of ETS oncogene family |
C00003491
|
| 2021 | ENDOG | endonuclease G |
C00003491
|
| 2064 | ERBB2, CD340, HER-2, HER-2/neu, HER2, MLN_19, NEU, NGL, TKR1 | v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (EC:2.7.10.1) |
C00003491
|
| 2066 | ERBB4, ALS19, HER4, p180erbB4 | v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 4 (EC:2.7.10.1) |
C00003491
|
| 2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 |
C00003491
|
| 2100 | ESR2, ER-BETA, ESR-BETA, ESRB, ESTRB, Erb, NR3A2 | estrogen receptor 2 (ER beta) |
C00003491
|
| 2152 | F3, CD142, TF, TFA | coagulation factor III (thromboplastin, tissue factor) |
C00003491
|
| 356 | FASLG, ALPS1B, APT1LG1, APTL, CD178, CD95-L, CD95L, FASL, TNFSF6 | Fas ligand (TNF superfamily, member 6) |
C00003491
|
| 2237 | FEN1, FEN-1, MF1, RAD2 | flap structure-specific endonuclease 1 |
C00003491
|
| 8823 | FGF16, FGF-16, MF4 | fibroblast growth factor 16 |
C00003491
|
| 2247 | FGF2, BFGF, FGF-2, FGFB, HBGF-2 | fibroblast growth factor 2 (basic) |
C00003491
|
| 2289 | FKBP5, AIG6, FKBP51, FKBP54, P54, PPIase, Ptg-10 | FK506 binding protein 5 (EC:5.2.1.8) |
C00003491
|
| 2321 | FLT1, FLT, FLT-1, VEGFR-1, VEGFR1 | fms-related tyrosine kinase 1 (EC:2.7.10.1) |
C00003491
|
| 2330 | FMO5 | flavin containing monooxygenase 5 (EC:1.14.13.8) |
C00003491
|
| 2335 | FN1, CIG, ED-B, FINC, FN, FNZ, GFND, GFND2, LETS, MSF | fibronectin 1 |
C00003491
|
| 2353 | FOS, AP-1, C-FOS, p55 | FBJ murine osteosarcoma viral oncogene homolog |
C00003491
|
| 2354 | FOSB, AP-1, G0S3, GOS3, GOSB | FBJ murine osteosarcoma viral oncogene homolog B |
C00003491
|
| 8061 | FOSL1, FRA, FRA1, fra-1 | FOS-like antigen 1 |
C00003491
|
| 2355 | FOSL2, FRA2 | FOS-like antigen 2 |
C00003491
|
| 2309 | FOXO3, AF6q21, FKHRL1, FKHRL1P2, FOXO2, FOXO3A | forkhead box O3 |
C00003491
|
| 2533 | FYB, ADAP, PRO0823, SLAP-130 | FYN binding protein |
C00003491
|
| 1647 | GADD45A, DDIT1, GADD45 | growth arrest and DNA-damage-inducible, alpha |
C00003491
|
| 2623 | GATA1, ERYF1, GATA-1, GF-1, GF1, NF-E1, NFE1, XLANP, XLTDA, XLTT | GATA binding protein 1 (globin transcription factor 1) |
C00003491
|
| 2624 | GATA2, DCML, MONOMAC, NFE1B | GATA binding protein 2 |
C00003491
|
| 2729 | GCLC, GCL, GCS, GLCL, GLCLC | glutamate-cysteine ligase, catalytic subunit (EC:6.3.2.2) |
C00003491
|
| 2662 | GDF10, BMP-3b, BMP3B | growth differentiation factor 10 |
C00003491
|
| 2672 | GFI1, GFI-1, GFI1A, SCN2, ZNF163 | growth factor independent 1 transcription repressor |
C00003491
|
| 2675 | GFRA2, GDNFRB, NRTNR-ALPHA, NTNRA, RETL2, TRNR2 | GDNF family receptor alpha 2 |
C00003491
|
| 2694 | GIF, IF, IFMH, INF, TCN3 | gastric intrinsic factor (vitamin B synthesis) |
C00003491
|
| 2697 | GJA1, AVSD3, CMDR, CX43, DFNB38, GJAL, HLHS1, HSS, ODDD | gap junction protein, alpha 1, 43kDa |
C00003491
|
| 10578 | GNLY, 519, D2S69E, LAG-2, LAG2, NKG5, TLA519 | granulysin |
C00003491
|
| 2798 | GNRHR, GNRHR1, GRHR, HH7, LHRHR, LRHR | gonadotropin-releasing hormone receptor |
C00003491
|
| 2876 | GPX1, GPXD, GSHPX1 | glutathione peroxidase 1 (EC:1.11.1.9) |
C00003491
|
| 2879 | GPX4, GPx-4, GSHPx-4, MCSP, PHGPx, snGPx, snPHGPx | glutathione peroxidase 4 (EC:1.11.1.12) |
C00003491
|
| 2896 | GRN, CLN11, GEP, GP88, PCDGF, PEPI, PGRN | granulin |
C00003491
|
| 2950 | GSTP1, DFN7, FAEES3, GST3, GSTP, PI | glutathione S-transferase pi 1 (EC:2.5.1.18) |
C00003491
|
| 2968 | GTF2H4, P52, TFB2, TFIIH | general transcription factor IIH, polypeptide 4, 52kDa |
C00003491
|
| 2993 | GYPA, CD235a, GPA, GPErik, GPSAT, HGpMiV, HGpMiXI, HGpSta(C), MN, MNS, PAS-2 | glycophorin A (MNS blood group) |
C00003491
|
| 3030 | HADHA, ECHA, GBP, HADH, LCEH, LCHAD, MTPA, TP-ALPHA | hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), alpha subunit (EC:4.2.1.17 1.1.1.211) |
C00003491
|
| 3035 | HARS, HRS, USH3B | histidyl-tRNA synthetase (EC:6.1.1.21) |
C00003491
|
| 1839 | HBEGF, DTR, DTS, DTSF, HEGFL | heparin-binding EGF-like growth factor |
C00003491
|
| 3055 | HCK, JTK9, p59Hck, p61Hck | hemopoietic cell kinase (EC:2.7.10.2) |
C00003491
|
| 3067 | HDC | histidine decarboxylase (EC:4.1.1.22) |
C00003491
|
| 3082 | HGF, DFNB39, F-TCF, HGFB, HPTA, SF | hepatocyte growth factor (hepapoietin A; scatter factor) |
C00003491
|
| 3091 | HIF1A, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1, PASD8, bHLHe78 | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
C00003491
|
| 3146 | HMGB1, HMG1, HMG3, SBP-1 | high mobility group box 1 |
C00003491
|
| 3156 | HMGCR, LDLCQ3 | 3-hydroxy-3-methylglutaryl-CoA reductase (EC:1.1.1.34) |
C00003491
|
| 3157 | HMGCS1, HMGCS | 3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble) (EC:2.3.3.10) |
C00003491
|
| 3162 | HMOX1, HMOX1D, HO-1, HSP32, bK286B10 | heme oxygenase (decycling) 1 (EC:1.14.99.3) |
C00003491
|
| 3248 | HPGD, 15-PGDH, PGDH, PGDH1, PHOAR1, SDR36C1 | hydroxyprostaglandin dehydrogenase 15-(NAD) (EC:1.1.1.141) |
C00003491
|
| 3265 | HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1 | Harvey rat sarcoma viral oncogene homolog |
C00003491
|
| 3306 | HSPA2, HSP70-2, HSP70-3 | heat shock 70kDa protein 2 |
C00003491
|
| 3310 | HSPA6 | heat shock 70kDa protein 6 (HSP70B') |
C00003491
|
| 3312 | HSPA8, HSC54, HSC70, HSC71, HSP71, HSP73, HSPA10, LAP1, NIP71 | heat shock 70kDa protein 8 |
C00003491
|
| 3313 | HSPA9, CSA, GRP-75, GRP75, HSPA9B, MOT, MOT2, MTHSP75, PBP74 | heat shock 70kDa protein 9 (mortalin) |
C00003491
|
| 3381 | IBSP, BNSP, BSP, BSP-II, SP-II | integrin-binding sialoprotein |
C00003491
|
| 3458 | IFNG, IFG, IFI | interferon, gamma |
C00003491
|
| 3460 | IFNGR2, AF-1, IFGR2, IFNGT1 | interferon gamma receptor 2 (interferon gamma transducer 1) |
C00003491
|
| 3488 | IGFBP5, IBP5 | insulin-like growth factor binding protein 5 |
C00003491
|
| 3490 | IGFBP7, AGM, FSTL2, IBP-7, IGFBP-7, IGFBP-7v, IGFBPRP1, MAC25, PSF, RAMSVPS, TAF | insulin-like growth factor binding protein 7 |
C00003491
|
| 3543 | IGLL1, 14.1, AGM2, CD179b, IGL1, IGL5, IGLJ14.1, IGLL, IGO, IGVPB, VPREB2 | immunoglobulin lambda-like polypeptide 1 |
C00003491
|
| 3551 | IKBKB, IKK-beta, IKK2, IKKB, NFKBIKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10) |
C00003491
|
| 8517 | IKBKG, AMCBX1, FIP-3, FIP3, Fip3p, IKK-gamma, IP, IP1, IP2, IPD2, NEMO, ZC2HC9 | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma |
C00003491
|
| 3586 | IL10, CSIF, GVHDS, IL-10, IL10A, TGIF | interleukin 10 |
C00003491
|
| 3589 | IL11, AGIF, IL-11 | interleukin 11 |
C00003491
|
| 3594 | IL12RB1, CD212, IL-12R-BETA1, IL12RB | interleukin 12 receptor, beta 1 |
C00003491
|
| 3595 | IL12RB2 | interleukin 12 receptor, beta 2 |
C00003491
|
| 3596 | IL13, IL-13, P600 | interleukin 13 |
C00003491
|
| 8809 | IL18R1, CD218a, CDw218a, IL-1Rrp, IL18RA, IL1RRP | interleukin 18 receptor 1 |
C00003491
|
| 3552 | IL1A, IL-1A, IL1, IL1-ALPHA, IL1F1 | interleukin 1, alpha |
C00003491
|
| 3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00003491
|
| 3554 | IL1R1, CD121A, D2S1473, IL-1R-alpha, IL1R, IL1RA, P80 | interleukin 1 receptor, type I |
C00003491
|
| 7850 | IL1R2, CD121b, CDw121b, IL-1R-2, IL-1RT-2, IL-1RT2, IL1R2c, IL1RB | interleukin 1 receptor, type II |
C00003491
|
| 3556 | IL1RAP, C3orf13, IL-1RAcP, IL1R3 | interleukin 1 receptor accessory protein |
C00003491
|
| 26280 | IL1RAPL2, IL-1R9, IL1R9, IL1RAPL-2, TIGIRR-1 | interleukin 1 receptor accessory protein-like 2 |
C00003491
|
| 3557 | IL1RN, DIRA, ICIL-1RA, IL-1RN, IL-1ra, IL-1ra3, IL1F3, IL1RA, IRAP, MVCD4 | interleukin 1 receptor antagonist |
C00003491
|
| 3558 | IL2, IL-2, TCGF, lymphokine | interleukin 2 |
C00003491
|
| 3559 | IL2RA, CD25, IDDM10, IL2R, TCGFR | interleukin 2 receptor, alpha |
C00003491
|
| 3560 | IL2RB, CD122, IL15RB, P70-75 | interleukin 2 receptor, beta |
C00003491
|
| 3562 | IL3, IL-3, MCGF, MULTI-CSF | interleukin 3 (colony-stimulating factor, multiple) |
C00003491
|
| 3565 | IL4, BCGF-1, BCGF1, BSF-1, BSF1, IL-4 | interleukin 4 |
C00003491
|
| 3567 | IL5, EDF, IL-5, TRF | interleukin 5 (colony-stimulating factor, eosinophil) |
C00003491
|
| 3568 | IL5RA, CD125, CDw125, HSIL5R3, IL5R | interleukin 5 receptor, alpha |
C00003491
|
| 3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) |
C00003491
|
| 3570 | IL6R, CD126, IL-6R-1, IL-6RA, IL6Q, IL6RA, IL6RQ, gp80 | interleukin 6 receptor |
C00003491
|
| 3581 | IL9R, CD129, IL-9R | interleukin 9 receptor |
C00003491
|
| 11213 | IRAK3, ASRT5, IRAKM | interleukin-1 receptor-associated kinase 3 (EC:2.7.11.1) |
C00003491
|
| 3662 | IRF4, LSIRF, MUM1, NF-EM5 | interferon regulatory factor 4 |
C00003491
|
| 3673 | ITGA2, BR, CD49B, GPIa, HPA-5, VLA-2, VLAA2 | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) |
C00003491
|
| 3674 | ITGA2B, BDPLT16, BDPLT2, CD41, CD41B, GP2B, GPIIb, GT, GTA, HPA3 | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) |
C00003491
|
| 3684 | ITGAM, CD11B, CR3A, MAC-1, MAC1A, MO1A, SLEB6 | integrin, alpha M (complement component 3 receptor 3 subunit) |
C00003491
|
| 3687 | ITGAX, CD11C, SLEB6 | integrin, alpha X (complement component 3 receptor 4 subunit) |
C00003491
|
| 3689 | ITGB2, CD18, LAD, LCAMB, LFA-1, MAC-1, MF17, MFI7 | integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
C00003491
|
| 3690 | ITGB3, BDPLT16, BDPLT2, CD61, GP3A, GPIIIa, GT | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) |
C00003491
|
| 3694 | ITGB6 | integrin, beta 6 |
C00003491
|
| 3713 | IVL | involucrin |
C00003491
|
| 3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene |
C00003491
|
| 3726 | JUNB, AP-1 | jun B proto-oncogene |
C00003491
|
| 3727 | JUND, AP-1 | jun D proto-oncogene |
C00003491
|
| 3752 | KCND3, KCND3L, KCND3S, KSHIVB, KV4.3, SCA19, SCA22 | potassium voltage-gated channel, Shal-related subfamily, member 3 |
C00003491
|
| 10112 | KIF20A, MKLP2, RAB6KIFL | kinesin family member 20A |
C00003491
|
| 9585 | KIF20B, CT90, KRMP1, MPHOSPH1, MPP-1, MPP1 | kinesin family member 20B |
C00003491
|
| 9493 | KIF23, CHO1, KNSL5, MKLP-1, MKLP1 | kinesin family member 23 |
C00003491
|
| 11004 | KIF2C, KNSL6, MCAK | kinesin family member 2C |
C00003491
|
| 11278 | KLF12, AP-2rep, AP2REP | Kruppel-like factor 12 |
C00003491
|
| 9314 | KLF4, EZF, GKLF | Kruppel-like factor 4 (gut) |
C00003491
|
| 1316 | KLF6, BCD1, CBA1, COPEB, CPBP, GBF, PAC1, ST12, ZF9 | Kruppel-like factor 6 |
C00003491
|
| 3845 | KRAS, C-K-RAS, CFC2, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2 | Kirsten rat sarcoma viral oncogene homolog |
C00003491
|
| 3912 | LAMB1, CLM, LIS5 | laminin, beta 1 |
C00003491
|
| 3936 | LCP1, CP64, L-PLASTIN, LC64P, LPL, PLS2 | lymphocyte cytosolic protein 1 (L-plastin) |
C00003491
|
| 3976 | LIF, CDF, DIA, HILDA, MLPLI | leukemia inhibitory factor |
C00003491
|
| 4005 | LMO2, RBTN2, RBTNL1, RHOM2, TTG2 | LIM domain only 2 (rhombotin-like 1) |
C00003491
|
| 4008 | LMO7, FBX20, FBXO20, LOMP | LIM domain 7 |
C00003491
|
| 4023 | LPL, HDLCQ11, LIPD | lipoprotein lipase (EC:3.1.1.34) |
C00003491
|
| 4035 | LRP1, A2MR, APOER, APR, CD91, IGFBP3R, LRP, LRP1A, TGFBR5 | low density lipoprotein receptor-related protein 1 |
C00003491
|
| 8425 | LTBP4, ARCL1C, LTBP-4, LTBP4L, LTBP4S | latent transforming growth factor beta binding protein 4 |
C00003491
|
| 8379 | MAD1L1, MAD1, PIG9, TP53I9, TXBP181 | MAD1 mitotic arrest deficient-like 1 (yeast) |
C00003491
|
| 4085 | MAD2L1, HSMAD2, MAD2 | MAD2 mitotic arrest deficient-like 1 (yeast) |
C00003491
|
| 81631 | MAP1LC3B, ATG8F, LC3B, MAP1A/1BLC3, MAP1LC3B-a | microtubule-associated protein 1 light chain 3 beta |
C00003491
|
| 5604 | MAP2K1, CFC3, MAPKK1, MEK1, MKK1, PRKMK1 | mitogen-activated protein kinase kinase 1 (EC:2.7.12.2) |
C00003491
|
| 5605 | MAP2K2, CFC4, MAPKK2, MEK2, MKK2, PRKMK2 | mitogen-activated protein kinase kinase 2 (EC:2.7.12.2) |
C00003491
|
| 9020 | MAP3K14, FTDCR1B, HS, HSNIK, NIK | mitogen-activated protein kinase kinase kinase 14 (EC:2.7.11.25) |
C00003491
|
| 5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00003491
|
| 5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00003491
|
| 9261 | MAPKAPK2, MAPKAP-K2, MK-2, MK2 | mitogen-activated protein kinase-activated protein kinase 2 (EC:2.7.11.1) |
C00003491
|
| 4153 | MBL2, COLEC1, HSMBPC, MBL, MBL2D, MBP, MBP-C, MBP1, MBPD | mannose-binding lectin (protein C) 2, soluble |
C00003491
|
| 4223 | MEOX2, GAX, MOX2 | mesenchyme homeobox 2 |
C00003491
|
| 10461 | MERTK, MER, RP38, c-mer | c-mer proto-oncogene tyrosine kinase (EC:2.7.10.1) |
C00003491
|
| 4255 | MGMT | O-6-methylguanine-DNA methyltransferase (EC:2.1.1.63) |
C00003491
|
| 8569 | MKNK1, MNK1 | MAP kinase interacting serine/threonine kinase 1 (EC:2.7.11.1) |
C00003491
|
| 4311 | MME, CALLA, CD10, NEP, SFE | membrane metallo-endopeptidase (EC:3.4.24.11) |
C00003491
|
| 4312 | MMP1, CLG, CLGN | matrix metallopeptidase 1 (interstitial collagenase) (EC:3.4.24.7) |
C00003491
|
| 4322 | MMP13, CLG3, MANDP1 | matrix metallopeptidase 13 (collagenase 3) (EC:3.4.24.-) |
C00003491
|
| 4323 | MMP14, MMP-14, MMP-X1, MT-MMP, MT-MMP_1, MT1-MMP, MT1MMP, MTMMP1, WNCHRS | matrix metallopeptidase 14 (membrane-inserted) (EC:3.4.24.80) |
C00003491
|
| 4313 | MMP2, CLG4, CLG4A, MMP-II, MONA, TBE-1 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) |
C00003491
|
| 118856 | MMP21, MMP-21 | matrix metallopeptidase 21 |
C00003491
|
| 4314 | MMP3, CHDS6, MMP-3, SL-1, STMY, STMY1, STR1 | matrix metallopeptidase 3 (stromelysin 1, progelatinase) (EC:3.4.24.17) |
C00003491
|
| 4317 | MMP8, CLG1, HNC, MMP-8, PMNL-CL | matrix metallopeptidase 8 (neutrophil collagenase) (EC:3.4.24.34) |
C00003491
|
| 4318 | MMP9, CLG4B, GELB, MANDP2, MMP-9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) |
C00003491
|
| 4353 | MPO | myeloperoxidase (EC:1.11.2.2) |
C00003491
|
| 10232 | MSLN, MPF, SMRP | mesothelin |
C00003491
|
| 4481 | MSR1, CD204, SCARA1, SR-A, SRA, phSR1, phSR2 | macrophage scavenger receptor 1 |
C00003491
|
| 4502 | MT2A, MT2 | metallothionein 2A |
C00003491
|
| 4582 | MUC1, CA_15-3, CD227, EMA, H23AG, KL-6, MAM6, MCKD1, MUC-1, MUC-1/SEC, MUC-1/X, MUC1/ZD, PEM, PEMT, PUM | mucin 1, cell surface associated |
C00003491
|
| 4609 | MYC, MRTL, MYCC, bHLHe39, c-Myc | v-myc avian myelocytomatosis viral oncogene homolog |
C00003491
|
| 7593 | MZF1, MZF-1, MZF1B, ZFP98, ZNF42, ZSCAN6 | myeloid zinc finger 1 |
C00003491
|
| 4675 | NAP1L3, MB20, NPL3 | nucleosome assembly protein 1-like 3 |
C00003491
|
| 24142 | NAT6, FUS-2, FUS2 | N-acetyltransferase 6 (GCN5-related) (EC:2.3.1.-) |
C00003491
|
| 64151 | NCAPG, CAPG, CHCG, NY-MEL-3 | non-SMC condensin I complex, subunit G |
C00003491
|
| 653361 | NCF1, NCF1A, NOXO2, SH3PXD1A, p47phox | neutrophil cytosolic factor 1 |
C00003491
|
| 4688 | NCF2, NCF-2, NOXA2, P67-PHOX, P67PHOX | neutrophil cytosolic factor 2 |
C00003491
|
| 4751 | NEK2, HsPK21, NEK2A, NLK1 | NIMA-related kinase 2 (EC:2.7.11.1) |
C00003491
|
| 4745 | NELL1, IDH3GL, NRP1 | NEL-like 1 (chicken) |
C00003491
|
| 4772 | NFATC1, NF-ATC, NFAT2, NFATc | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
C00003491
|
| 4773 | NFATC2, NFAT1, NFATP | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 |
C00003491
|
| 4775 | NFATC3, NFAT4, NFATX | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3 |
C00003491
|
| 4776 | NFATC4, NF-ATc4, NFAT3 | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4 |
C00003491
|
| 4781 | NFIB, CTF, HMGIC/NFIB, NF-I/B, NF1-B, NFI-B, NFI-RED, NFIB2, NFIB3 | nuclear factor I/B |
C00003491
|
| 4790 | NFKB1, EBP-1, KBF1, NF-kB1, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, NFkappaB, p105, p50 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
C00003491
|
| 4792 | NFKBIA, IKBA, MAD-3, NFKBI | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
C00003491
|
| 4795 | NFKBIL1, IKBL, LST1, NFKBIL | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1 |
C00003491
|
| 4818 | NKG7, GIG1, GMP-17, p15-TIA-1 | natural killer cell group 7 sequence |
C00003491
|
| 9111 | NMI | N-myc (and STAT) interactor |
C00003491
|
| 9221 | NOLC1, NOPP130, NOPP140, NS5ATP13, P130 | nucleolar and coiled-body phosphoprotein 1 |
C00003491
|
| 4843 | NOS2, HEP-NOS, INOS, NOS, NOS2A | nitric oxide synthase 2, inducible (EC:1.14.13.39) |
C00003491
|
| 404036 |
C00003491
|
||
| 4854 | NOTCH3, CADASIL, CASIL, IMF2 | notch 3 |
C00003491
|
| 124056 | NOXO1, P41NOX, P41NOXA, P41NOXB, P41NOXC, SH3PXD5, SNX28 | NADPH oxidase organizer 1 |
C00003491
|
| 1728 | NQO1, DHQU, DIA4, DTD, NMOR1, NMORI, QR1 | NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) |
C00003491
|
| 4835 | NQO2, DHQV, DIA6, NMOR2, QR2 | NAD(P)H dehydrogenase, quinone 2 (EC:1.10.99.2) |
C00003491
|
| 3164 | NR4A1, GFRP1, HMR, N10, NAK-1, NGFIB, NP10, NUR77, TR3 | nuclear receptor subfamily 4, group A, member 1 |
C00003491
|
| 4929 | NR4A2, HZF-3, NOT, NURR1, RNR1, TINUR | nuclear receptor subfamily 4, group A, member 2 |
C00003491
|
| 8013 | NR4A3, CHN, CSMF, MINOR, NOR1, TEC | nuclear receptor subfamily 4, group A, member 3 |
C00003491
|
| 2494 | NR5A2, B1F, B1F2, CPF, FTF, FTZ-F1, FTZ-F1beta, LRH-1, LRH1, hB1F-2 | nuclear receptor subfamily 5, group A, member 2 |
C00003491
|
| 51203 | NUSAP1, ANKT, BM037, LNP, NUSAP, PRO0310p1, Q0310, SAPL | nucleolar and spindle associated protein 1 |
C00003491
|
| 4953 | ODC1, ODC | ornithine decarboxylase 1 (EC:4.1.1.17) |
C00003491
|
| 4988 | OPRM1, LMOR, M-OR-1, MOP, MOR, MOR1, OPRM | opioid receptor, mu 1 |
C00003491
|
| 5063 | PAK3, CDKN1A, MRX30, MRX47, OPHN3, PAK3beta, bPAK, hPAK3 | p21 protein (Cdc42/Rac)-activated kinase 3 (EC:2.7.11.1) |
C00003491
|
| 10038 | PARP2, ADPRT2, ADPRTL2, ADPRTL3, ARTD2, PARP-2, pADPRT-2 | poly (ADP-ribose) polymerase 2 (EC:2.4.2.30) |
C00003491
|
| 55872 | PBK, CT84, Nori-3, SPK, TOPK | PDZ binding kinase (EC:2.7.12.2) |
C00003491
|
| 56146 | PCDHA2, PCDH-ALPHA2 | protocadherin alpha 2 |
C00003491
|
| 5118 | PCOLCE, PCPE, PCPE-1, PCPE1 | procollagen C-endopeptidase enhancer |
C00003491
|
| 27250 | PDCD4, H731 | programmed cell death 4 (neoplastic transformation inhibitor) |
C00003491
|
| 5154 | PDGFA, PDGF-A, PDGF1 | platelet-derived growth factor alpha polypeptide |
C00003491
|
| 5155 | PDGFB, IBGC5, PDGF-2, PDGF2, SIS, SSV, c-sis | platelet-derived growth factor beta polypeptide |
C00003491
|
| 5241 | PGR, NR3C3, PR | progesterone receptor |
C00003491
|
| 5300 | PIN1, DOD, UBL5 | peptidylprolyl cis/trans isomerase, NIMA-interacting 1 (EC:5.2.1.8) |
C00003491
|
| 5320 | PLA2G2A, MOM1, PLA2, PLA2B, PLA2L, PLA2S, PLAS1, sPLA2 | phospholipase A2, group IIA (platelets, synovial fluid) (EC:3.1.1.4) |
C00003491
|
| 5327 | PLAT, T-PA, TPA | plasminogen activator, tissue (EC:3.4.21.68) |
C00003491
|
| 5328 | PLAU, ATF, BDPLT5, QPD, UPA, URK, u-PA | plasminogen activator, urokinase (EC:3.4.21.73) |
C00003491
|
| 5330 | PLCB2, PLC-beta-2 | phospholipase C, beta 2 (EC:3.1.4.11) |
C00003491
|
| 5338 | PLD2 | phospholipase D2 (EC:3.1.4.4) |
C00003491
|
| 5347 | PLK1, PLK, STPK13 | polo-like kinase 1 (EC:2.7.11.21) |
C00003491
|
| 8228 | PNPLA4, DXS1283E, GS2, iPLA2eta | patatin-like phospholipase domain containing 4 (EC:3.1.1.3) |
C00003491
|
| 5427 | POLE2, DPE2 | polymerase (DNA directed), epsilon 2, accessory subunit (EC:2.7.7.7) |
C00003491
|
| 5451 | POU2F1, OCT1, OTF1, oct-1B | POU class 2 homeobox 1 |
C00003491
|
| 5452 | POU2F2, OCT2, OTF2, Oct-2 | POU class 2 homeobox 2 |
C00003491
|
| 5459 | POU4F3, BRN3C, DFNA15 | POU class 4 homeobox 3 |
C00003491
|
| 5465 | PPARA, NR1C1, PPAR, PPARalpha, hPPAR | peroxisome proliferator-activated receptor alpha |
C00003491
|
| 5473 | PPBP, B-TG1, Beta-TG, CTAP-III, CTAP3, CTAPIII, CXCL7, LA-PF4, LDGF, MDGF, NAP-2, PBP, SCYB7, TC1, TC2, TGB, TGB1, THBGB, THBGB1 | pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) |
C00003491
|
| 5580 | PRKCD, MAY1, PKCD, nPKC-delta | protein kinase C, delta (EC:2.7.10.2 2.7.11.13) |
C00003491
|
| 5581 | PRKCE, PKCE, nPKC-epsilon | protein kinase C, epsilon (EC:2.7.11.13) |
C00003491
|
| 5583 | PRKCH, PKC-L, PKCL, PRKCL, nPKC-eta | protein kinase C, eta (EC:2.7.11.13) |
C00003491
|
| 5584 | PRKCI, DXS1179E, PKCI, nPKC-iota | protein kinase C, iota (EC:2.7.11.13) |
C00003491
|
| 5588 | PRKCQ, PRKCT, nPKC-theta | protein kinase C, theta (EC:2.7.11.13) |
C00003491
|
| 5590 | PRKCZ, PKC-ZETA, PKC2 | protein kinase C, zeta (EC:2.7.11.13) |
C00003491
|
| 9536 | PTGES, MGST-IV, MGST1-L1, MGST1L1, MPGES, PGES, PIG12, PP102, PP1294, TP53I12, mPGES-1 | prostaglandin E synthase (EC:5.3.99.3) |
C00003491
|
| 5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00003491
|
| 5747 | PTK2, FADK, FAK, FAK1, FRNK, PPP1R71, p125FAK, pp125FAK | protein tyrosine kinase 2 (EC:2.7.10.2) |
C00003491
|
| 5799 | PTPRN2, IA-2beta, IAR, ICAAR, PTPRP, R-PTP-N2 | protein tyrosine phosphatase, receptor type, N polypeptide 2 (EC:3.1.3.48) |
C00003491
|
| 9232 | PTTG1, EAP1, HPTTG, PTTG, TUTR1 | pituitary tumor-transforming 1 |
C00003491
|
| 5806 | PTX3, TNFAIP5, TSG-14 | pentraxin 3, long |
C00003491
|
| 5879 | RAC1, Rac-1, TC-25, p21-Rac1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) |
C00003491
|
| 10635 | RAD51AP1, PIR51 | RAD51 associated protein 1 |
C00003491
|
| 5889 | RAD51C, BROVCA3, FANCO, R51H3, RAD51L2 | RAD51 paralog C |
C00003491
|
| 8438 | RAD54L, HR54, RAD54A, hHR54, hRAD54 | RAD54-like (S. cerevisiae) |
C00003491
|
| 5918 | RARRES1, LXNL, TIG1 | retinoic acid receptor responder (tazarotene induced) 1 |
C00003491
|
| 5925 | RB1, OSRC, RB, p105-Rb, pRb, pp110 | retinoblastoma 1 |
C00003491
|
| 5932 | RBBP8, COM1, CTIP, JWDS, RIM, SAE2, SCKL2 | retinoblastoma binding protein 8 |
C00003491
|
| 9978 | RBX1, BA554C12.1, RNF75, ROC1 | ring-box 1, E3 ubiquitin protein ligase |
C00003491
|
| 5966 | REL, C-Rel | v-rel avian reticuloendotheliosis viral oncogene homolog |
C00003491
|
| 5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00003491
|
| 5984 | RFC4, A1, RFC37 | replication factor C (activator 1) 4, 37kDa |
C00003491
|
| 5985 | RFC5, RFC36 | replication factor C (activator 1) 5, 36.5kDa |
C00003491
|
| 28984 | RGCC, C13orf15, RGC-32, RGC32, bA157L14.2 | regulator of cell cycle |
C00003491
|
| 8786 | RGS11, RS11 | regulator of G-protein signaling 11 |
C00003491
|
| 6003 | RGS13 | regulator of G-protein signaling 13 |
C00003491
|
| 391 | RHOG, ARHG | ras homolog family member G |
C00003491
|
| 8635 | RNASET2, RNASE6PL, bA514O12.3 | ribonuclease T2 (EC:3.1.27.1) |
C00003491
|
| 6194 | RPS6, S6 | ribosomal protein S6 |
C00003491
|
| 6279 | S100A8, 60B8AG, CAGA, CFAG, CGLA, CP-10, L1Ag, MA387, MIF, MRP8, NIF, P8 | S100 calcium binding protein A8 |
C00003491
|
| 6280 | S100A9, 60B8AG, CAGB, CFAG, CGLB, L1AG, LIAG, MAC387, MIF, MRP14, NIF, P14 | S100 calcium binding protein A9 |
C00003491
|
| 6286 | S100P, MIG9 | S100 calcium binding protein P |
C00003491
|
| 9092 | SART1, Ara1, HOMS1, SART1259, SNRNP110, Snu66 | squamous cell carcinoma antigen recognized by T cells |
C00003491
|
| 6382 | SDC1, CD138, SDC, SYND1, syndecan | syndecan 1 |
C00003491
|
| 6385 | SDC4, SYND4 | syndecan 4 |
C00003491
|
| 6401 | SELE, CD62E, ELAM, ELAM1, ESEL, LECAM2 | selectin E |
C00003491
|
| 5055 | SERPINB2, HsT1201, PAI, PAI-2, PAI2, PLANH2 | serpin peptidase inhibitor, clade B (ovalbumin), member 2 |
C00003491
|
| 5272 | SERPINB9, CAP-3, CAP3, PI-9, PI9 | serpin peptidase inhibitor, clade B (ovalbumin), member 9 |
C00003491
|
| 331 | XIAP, API3, BIRC4, IAP-3, ILP1, MIHA, XLP2, hIAP-3, hIAP3 | X-linked inhibitor of apoptosis |
C00003494
|
| 10262 | SF3B4, AFD1, Hsh49, SAP49, SF3b49 | splicing factor 3b, subunit 4, 49kDa |
C00003491
|
| 22941 | SHANK2, AUTS17, CORTBP1, CTTNBP1, ProSAP1, SHANK, SPANK-3 | SH3 and multiple ankyrin repeat domains 2 |
C00003491
|
| 6464 | SHC1, SHC, SHCA | SHC (Src homology 2 domain containing) transforming protein 1 |
C00003491
|
| 7979 | SHFM1, DSS1, ECD, SEM1, SHFD1, SHSF1, Shfdg1 | split hand/foot malformation (ectrodactyly) type 1 |
C00003491
|
| 946 | SIGLEC6, CD327, CD33L, CD33L1, CD33L2, CDW327, OBBP1 | sialic acid binding Ig-like lectin 6 |
C00003491
|
| 6503 | SLA, SLA1, SLAP | Src-like-adaptor |
C00003491
|
| 6520 | SLC3A2, 4F2, 4F2HC, 4T2HC, CD98, CD98HC, MDU1, NACAE | solute carrier family 3 (amino acid transporter heavy chain), member 2 |
C00003491
|
| 8884 | SLC5A6, SMVT | solute carrier family 5 (sodium/multivitamin and iodide cotransporter), member 6 |
C00003491
|
| 6531 | SLC6A3, DAT, DAT1, PKDYS | solute carrier family 6 (neurotransmitter transporter), member 3 |
C00003491
|
| 23657 | SLC7A11, CCBR1, xCT | solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 |
C00003491
|
| 10051 | SMC4, CAP-C, CAPC, SMC-4, SMC4L1, hCAP-C | structural maintenance of chromosomes 4 |
C00003491
|
| 8835 | SOCS2, CIS2, Cish2, SOCS-2, SSI-2, SSI2, STATI2 | suppressor of cytokine signaling 2 |
C00003491
|
| 6647 | SOD1, ALS, ALS1, IPOA, SOD, hSod1, homodimer | superoxide dismutase 1, soluble (EC:1.15.1.1) |
C00003491
|
| 6648 | SOD2, IPOB, MNSOD, MVCD6 | superoxide dismutase 2, mitochondrial (EC:1.15.1.1) |
C00003491
|
| 6667 | SP1 | Sp1 transcription factor |
C00003491
|
| 10615 | SPAG5, DEEPEST, MAP126, hMAP126 | sperm associated antigen 5 |
C00003491
|
| 6688 | SPI1, OF, PU.1, SFPI1, SPI-1, SPI-A | spleen focus forming virus (SFFV) proviral integration oncogene |
C00003491
|
| 6696 | SPP1, BNSP, BSPI, ETA-1, OPN | secreted phosphoprotein 1 |
C00003491
|
| 6698 | SPRR1A, SPRK | small proline-rich protein 1A |
C00003491
|
| 6699 | SPRR1B, CORNIFIN, GADD33, SPRR1 | small proline-rich protein 1B |
C00003491
|
| 6700 | SPRR2A | small proline-rich protein 2A |
C00003491
|
| 6734 | SRPR, DP, Sralpha | signal recognition particle receptor (docking protein) |
C00003491
|
| 10492 | SYNCRIP, GRY-RBP, GRYRBP, HNRNPQ, HNRPQ1, NSAP1, PP68, hnRNP-Q | synaptotagmin binding, cytoplasmic RNA interacting protein |
C00003491
|
| 8148 | TAF15, Npl3, RBP56, TAF2N, TAFII68 | TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 68kDa |
C00003491
|
| 6876 | TAGLN, SM22, SMCC, TAGLN1, WS3-10 | transgelin |
C00003491
|
| 7031 | TFF1, BCEI, D21S21, HP1.A, HPS2, pNR-2, pS2 | trefoil factor 1 |
C00003491
|
| 7037 | TFRC, CD71, T9, TFR, TFR1, TR, TRFR, p90 | transferrin receptor |
C00003491
|
| 7040 | TGFB1, CED, DPD1, LAP, TGFB, TGFbeta | transforming growth factor, beta 1 |
C00003491
|
| 7042 | TGFB2, LDS4, TGF-beta2 | transforming growth factor, beta 2 |
C00003491
|
| 7051 | TGM1, ARCI1, ICR2, KTG, LI, LI1, TGASE, TGK | transglutaminase 1 (EC:2.3.2.13) |
C00003491
|
| 7066 | THPO, MGDF, MKCSF, ML, MPLLG, THCYT1, TPO | thrombopoietin |
C00003491
|
| 10440 | TIMM17A, TIM17, TIM17A | translocase of inner mitochondrial membrane 17 homolog A (yeast) |
C00003491
|
| 7076 | TIMP1, CLGI, EPA, EPO, HCI, TIMP | TIMP metallopeptidase inhibitor 1 |
C00003491
|
| 7077 | TIMP2, CSC-21K, DDC8 | TIMP metallopeptidase inhibitor 2 |
C00003491
|
| 10333 | TLR6, CD286 | toll-like receptor 6 |
C00003491
|
| 3371 | TNC, 150-225, DFNA56, GMEM, GP, HXB, JI, TN, TN-C | tenascin C |
C00003491
|
| 7128 | TNFAIP3, A20, OTUD7C, TNFA1P2 | tumor necrosis factor, alpha-induced protein 3 (EC:3.4.19.12) |
C00003491
|
| 7132 | TNFRSF1A, CD120a, FPF, MS5, TBP1, TNF-R, TNF-R-I, TNF-R55, TNFAR, TNFR1, TNFR1-d2, TNFR55, TNFR60, p55, p55-R, p60 | tumor necrosis factor receptor superfamily, member 1A |
C00003491
|
| 7133 | TNFRSF1B, CD120b, TBPII, TNF-R-II, TNF-R75, TNFBR, TNFR1B, TNFR2, TNFR80, p75, p75TNFR | tumor necrosis factor receptor superfamily, member 1B |
C00003491
|
| 3604 | TNFRSF9, 4-1BB, CD137, CDw137, ILA | tumor necrosis factor receptor superfamily, member 9 |
C00003491
|
| 8743 | TNFSF10, APO2L, Apo-2L, CD253, TL2, TRAIL | tumor necrosis factor (ligand) superfamily, member 10 |
C00003491
|
| 7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00003491
|
| 7163 | TPD52, D52, N8L, PC-1, PrLZ, hD52 | tumor protein D52 |
C00003491
|
| 22974 | TPX2, C20orf1, C20orf2, DIL-2, DIL2, FLS353, GD:C20orf1, HCA519, HCTP4, REPP86, p100 | TPX2, microtubule-associated |
C00003491
|
| 7185 | TRAF1, EBI6, MGC:10353 | TNF receptor-associated factor 1 |
C00003491
|
| 6967 |
C00003491
|
||
| 29953 | TRHDE, PAP-II, PGPEP2, TRH-DE | thyrotropin-releasing hormone degrading enzyme (EC:3.4.19.6) |
C00003491
|
| 28951 | TRIB2, C5FW, GS3955, TRB2 | tribbles pseudokinase 2 |
C00003491
|
| 7296 | TXNRD1, GRIM-12, TR, TR1, TRXR1, TXNR | thioredoxin reductase 1 (EC:1.8.1.9) |
C00003491
|
| 1890 | TYMP, ECGF, ECGF1, MEDPS1, MNGIE, MTDPS1, PDECGF, TP, hPD-ECGF | thymidine phosphorylase (EC:2.4.2.4) |
C00003491
|
| 7298 | TYMS, HST422, TMS, TS | thymidylate synthetase (EC:2.1.1.45) |
C00003491
|
| 7305 | TYROBP, DAP12, KARAP, PLOSL | TYRO protein tyrosine kinase binding protein |
C00003491
|
| 29128 | UHRF1, ICBP90, Np95, RNF106, hNP95, hUHRF1 | ubiquitin-like with PHD and ring finger domains 1 (EC:6.3.2.19) |
C00003491
|
| 7412 | VCAM1, CD106, INCAM-100 | vascular cell adhesion molecule 1 |
C00003491
|
| 7422 | VEGFA, MVCD1, VEGF, VPF | vascular endothelial growth factor A |
C00003491
|
| 7431 | VIM, CTRCT30 | vimentin |
C00003491
|
| 7434 | VIPR2, C16DUPq36.3, DUP7q36.3, PACAP-R-3, PACAP-R3, VIP-R-2, VPAC2, VPAC2R, VPCAP2R | vasoactive intestinal peptide receptor 2 |
C00003491
|
| 6935 | ZEB1, AREB6, BZP, DELTAEF1, FECD6, NIL2A, PPCD3, TCF8, ZFHEP, ZFHX1A | zinc finger E-box binding homeobox 1 |
C00003491
|
| 9839 | ZEB2, HSPC082, SIP-1, SIP1, SMADIP1, ZFHX1B | zinc finger E-box binding homeobox 2 |
C00003491
|
| 9310 | ZNF235, ANF270, HZF6, ZFP93, ZNF270 | zinc finger protein 235 |
C00003491
|
| 113835 | ZNF257, BMZF-4, BMZF4 | zinc finger protein 257 |
C00003491
|
| 11130 | ZWINT, HZwint-1, KNTC2AP, ZWINT1 | ZW10 interacting kinetochore protein |
C00003491
|
| OMIM | preferred title | UniProt |
|---|---|---|
| #300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
| #300018 | 46,xy sex reversal 2; srxy2 |
P51843
|
| #100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
| #219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
| #300200 | Adrenal hypoplasia, congenital; ahc |
P51843
|
| #202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
| #103470 | Albinism, ocular, with sensorineural deafness |
O75030
|
| #103780 | Alcohol dependence |
P08172
P14416 P31645 |
| #612069 | Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia; als10 |
Q13148
|
| #614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
| #300068 | Androgen insensitivity syndrome; ais |
P10275
|
| #312300 | Androgen insensitivity, partial; pais |
P10275
|
| #608584 | Asthma-related traits, susceptibility to, 2 |
Q6W5P4
|
| #614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
| #606798 | Blepharospasm, benign essential |
P21918
|
| #210900 | Bloom syndrome; blm |
P54132
|
| #602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
| %606641 | Body mass index; bmi |
P37231
|
| #300615 | Brunner syndrome |
P21397
|
| #115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
| #212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
| #609338 | Carotid intimal medial thickness 1 |
P37231
|
| #118300 | Charcot-marie-tooth disease and deafness |
Q01453
|
| #605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
| #118220 | Charcot-marie-tooth disease, demyelinating, type 1a; cmt1a |
Q01453
|
| #300905 | Charcot-marie-tooth disease, x-linked dominant, 6; cmtx6 |
Q15120
|
| #114500 | Colorectal cancer; crc |
P18054
P84022 |
| #219050 | Cryptorchidism, unilateral or bilateral |
Q8WXD0
|
| #162800 | Cyclic neutropenia |
P08246
|
| #219700 | Cystic fibrosis; cf |
P13569
|
| #127750 | Dementia, lewy body; dlb |
P37840
|
| #612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
| #119900 | Digital clubbing, isolated congenital |
P15428
|
| #607208 | Dravet syndrome |
P35498
|
| #609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
| #608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
| #606703 | Dyskinesia, familial, with facial myokymia; fdfm |
O95622
|
| #601042 | Dystonia 9; dyt9 |
P11166
|
| #181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
| #614847 | Epilepsy, idiopathic generalized, susceptibility to, 12; eig12 |
P11166
|
| #613721 | Epileptic encephalopathy, early infantile, 11; eiee11 |
Q99250
|
| #133239 | Esophageal cancer |
P04637
P18054 |
| #615363 | Estrogen resistance; estrr |
P03372
|
| #600274 | Frontotemporal dementia; ftd |
P10636
|
| #613659 | Gastric cancer |
P04626
|
| #137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
| #609446 | Generalized epilepsy and paroxysmal dyskinesia; gepd |
Q12791
|
| #604403 | Generalized epilepsy with febrile seizures plus, type 2; gefsp2 |
P35498
|
| #231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
| #137800 | Glioma susceptibility 1; glm1 |
O75874
P04626 P37231 |
| #606777 | Glut1 deficiency syndrome 1; glut1ds1 |
P11166
|
| #612126 | Glut1 deficiency syndrome 2; glut1ds2 |
P11166
|
| #139393 | Guillain-barre syndrome, familial; gbs |
Q01453
|
| #605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
| #610140 | Heart-hand syndrome, slovenian type |
P02545
|
| #609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
| #143100 | Huntington disease; hd |
P42858
|
| #176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
| #145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
| #603373 | Hyperthyroidism, familial gestational |
P16473
|
| #609152 | Hyperthyroidism, nonautoimmune |
P16473
|
| #145900 | Hypertrophic neuropathy of dejerine-sottas |
Q01453
|
| #259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
| #275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
| #612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
| #603932 | Intervertebral disc disease; idd |
P14780
|
| #151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
| #151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
| #604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
| #613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
| #613688 | Long qt syndrome 2; lqt2 |
Q12809
|
| #211980 | Lung cancer |
P00533
P04626 P04637 |
| #608516 | Major depressive disorder; mdd |
P08172
|
| #248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
| #174800 | Mccune-albright syndrome; mas |
P63092
|
| #614456 | Melanoma, cutaneous malignant, susceptibility to, 8; cmm8 |
O75030
|
| #300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
| %300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
| #300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
| #613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
| #609634 | Migraine, familial hemiplegic, 3; fhm3 |
P35498
|
| #131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
| #126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
| #613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
| #159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
| #607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
| #159900 | Myoclonic dystonia |
P14416
|
| #160900 | Myotonic dystrophy 1; dm1 |
Q9NR56
|
| #158580 | Neuronopathy, distal hereditary motor, type viia; hmn7a |
Q9GZV3
|
| #162500 | Neuropathy, hereditary, with liability to pressure palsies; hnpp |
Q01453
|
| #202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
| #257200 | Niemann-pick disease, type a |
P17405
|
| #607616 | Niemann-pick disease, type b |
P17405
|
| #257220 | Niemann-pick disease, type c1; npc1 |
O15118
|
| #601665 | Obesity |
P32245
P37231 |
| #164230 | Obsessive-compulsive disorder; ocd |
P31645
|
| #604715 | Orthostatic intolerance |
P23975
|
| #166350 | Osseous heteroplasia, progressive; poh |
P63092
|
| #259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
| #167000 | Ovarian cancer |
P04626
|
| #260500 | Papilloma of choroid plexus; cpp |
P04637
|
| #168601 | Parkinson disease 1, autosomal dominant; park1 |
P37840
|
| #605543 | Parkinson disease 4, autosomal dominant; park4 |
P37840
|
| #168600 | Parkinson disease, late-onset; pd |
P37840
|
| #260540 | Parkinson-dementia syndrome |
P10636
|
| #613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
| #614674 | Periodic fever, menstrual cycle-dependent |
P08908
|
| #172700 | Pick disease of brain |
P10636
|
| #102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
| #601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
| #103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
| #603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
| #612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
| #607276 | Resting heart rate, variation in |
P08588
|
| #275210 | Restrictive dermopathy, lethal |
P02545
|
| #604906 | Schizophrenia 9; sczd9 |
P49798
|
| #181500 | Schizophrenia; sczd |
P49798
|
| #607745 | Seizures, benign familial infantile, 3; bfis3 |
Q99250
|
| #608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
| #609620 | Short qt syndrome 1; sqt1 |
Q12809
|
| #313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
| #253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
| #253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
| #253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
| #271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
| #605361 | Spinocerebellar ataxia 14; sca14 |
P05129
|
| #183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
| #607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
| #275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
| #601367 | Stroke, ischemic |
P24723
|
| #601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
| #152700 | Systemic lupus erythematosus; sle |
O95267
|
| #187950 | Thrombocythemia 1; thcyt1 |
P40225
|
| #103500 | Tietz syndrome |
O75030
|
| #190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
| #277180 | Vas deferens, congenital bilateral aplasia of; cbavd |
P13569
|
| #277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
| #193510 | Waardenburg syndrome, type 2a; ws2a |
O75030
|
| #610379 | West nile virus, susceptibility to |
P51681
|
| #278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
| #112100 | Yt blood group antigen |
P22303
|
| KEGG | name | UniProt |
|---|---|---|
| H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
| H00034 | Carcinoid |
O00255
(related)
|
| H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
| H00246 | Primary hyperparathyroidism |
O00255
(related)
|
| H01102 | Pituitary adenomas |
O00255
(related)
|
| H00136 | Niemann-Pick disease type C (NPC) |
O15118
(related)
|
| H00038 | Malignant melanoma |
O75030
(related)
O75030 (marker) P04637 (related) |
| H00169 | Ocular albinism |
O75030
(related)
|
| H00759 | Waardenburg syndrome (WS) |
O75030
(related)
|
| H01187 | Tietz syndrome |
O75030
(related)
|
| H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
| H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) P35354 (related) |
| H00018 | Gastric cancer |
P00533
(related)
P04626 (related) P04637 (related) |
| H00022 | Bladder cancer |
P00533
(related)
P04626 (related) P04637 (related) |
| H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) P04637 (related) |
| H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
| H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
| H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
| H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
| H00436 | Osteopetrosis |
P00918
(related)
|
| H00081 | Hashimoto's thyroiditis |
P01215
(marker)
|
| H00082 | Graves' disease |
P01215
(marker)
|
| H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P01215
(marker)
P16473 (related) |
| H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
Q01453 (related) |
| H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
| H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
P37231 (related) |
| H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
| H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
| H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
| H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
| H00663 | Restrictive dermopathy |
P02545
(related)
|
| H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
| H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
| H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) P04637 (related) Q92731 (marker) |
| H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
| H00019 | Pancreatic cancer |
P04626
(related)
P04637 (related) P04637 (marker) |
| H00027 | Ovarian cancer |
P04626
(related)
P04637 (related) |
| H00031 | Breast cancer |
P04626
(related)
P04626 (marker) P04637 (related) |
| H00046 | Cholangiocarcinoma |
P04626
(related)
P04637 (related) P35354 (related) |
| H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
Q01196 (related) |
| H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
| H00006 | Hairy-cell leukemia |
P04637
(related)
|
| H00008 | Burkitt lymphoma |
P04637
(related)
|
| H00009 | Adult T-cell leukemia |
P04637
(related)
|
| H00010 | Multiple myeloma |
P04637
(related)
|
| H00013 | Small cell lung cancer |
P04637
(related)
|
| H00014 | Non-small cell lung cancer |
P04637
(related)
|
| H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
| H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
| H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P14780 (related) P35354 (related) |
| H00029 | Vulvar cancer |
P04637
(related)
|
| H00032 | Thyroid cancer |
P04637
(related)
P37231 (related) |
| H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
| H00039 | Basal cell carcinoma |
P04637
(related)
|
| H00040 | Squamous cell carcinoma |
P04637
(related)
|
| H00041 | Kaposi's sarcoma |
P04637
(related)
|
| H00044 | Cancer of the anal canal |
P04637
(related)
|
| H00047 | Gallbladder cancer |
P04637
(related)
|
| H00048 | Hepatocellular carcinoma |
P04637
(related)
|
| H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
| H01007 | Choroid plexus papilloma |
P04637
(related)
|
| H00021 | Renal cell carcinoma |
P04637
(marker)
|
| H00063 | Spinocerebellar ataxia (SCA) |
P05129
(related)
Q99700 (related) Q9NUW8 (related) |
| H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
| H00079 | Asthma |
P07550
(related)
|
| H00100 | Neutropenic disorders |
P08246
(related)
|
| H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
| H00024 | Prostate cancer |
P10275
(related)
|
| H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
| H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
| H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
Q8WXD0 (related) |
| H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
Q13148 (related) |
| H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
| H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
| H00831 | Primary dystonia |
P11166
(related)
|
| H00836 | GLUT1 deficiency syndrome (GLUT1DS) |
P11166
(related)
|
| H00342 | Tuberculosis |
P11473
(related)
|
| H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
| H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
| H01205 | Coumarin resistance |
P11712
(related)
|
| H00218 | Cystic fibrosis (CF) |
P13569
(related)
|
| H00933 | Hereditary pancreatitis |
P13569
(related)
|
| H01033 | Congenital bilateral absence of vas deferens |
P13569
(related)
|
| H00479 | Metaphyseal dysplasias |
P14780
(related)
|
| H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
| H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
| H01269 | Congenital hyperthyroidism |
P16473
(related)
|
| H00137 | Niemann-Pick disease (NPD) typeA and B |
P17405
(related)
|
| H00424 | Defects in the degradation of sphingomyelin |
P17405
(related)
|
| H00548 | Brunner syndrome |
P21397
(related)
|
| H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
| H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
| H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
| H00775 | Familial or sporadic hemiplegic migraine |
P35498
(related)
|
| H00783 | Febrile seizures |
P35498
(related)
|
| H00409 | Type II diabetes mellitus |
P37231
(related)
|
| H00057 | Parkinson's disease (PD) |
P37840
(related)
|
| H00066 | Lewy body dementia (LBD) |
P37840
(related)
|
| H00227 | Congenital amegakaryocytic thrombocytopenia (CAMT) |
P40225
(marker)
|
| H00059 | Huntington's disease (HD) |
P42858
(related)
|
| H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
Q99714 (related) |
| H00552 | Glycerol kinase deficiency (GKD) |
P51843
(related)
|
| H00607 | 46,XY disorders of sex development (Disorders of gonadal development) |
P51843
(related)
|
| H00094 | DNA repair defects |
P54132
(related)
|
| H00296 | Defects in RecQ helicases |
P54132
(related)
|
| H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
| H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
| H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
| H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
| H00003 | Acute myeloid leukemia (AML) |
Q01196
(related)
Q01196 (marker) Q13951 (marker) |
| H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
| H01296 | Hereditary neuropathy with liability to pressure palsies (HNPP) |
Q01453
(related)
|
| H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
| H00408 | Type I diabetes mellitus |
Q04759
(related)
|
| H01258 | Generalized epilepsy and paroxysmal dyskinesia (GEPD) |
Q12791
(related)
|
| H00720 | Long QT syndrome |
Q12809
(related)
|
| H00725 | Short QT syndrome |
Q12809
(related)
|
| H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
| H00606 | Early infantile epileptic encephalopathy |
Q99250
(related)
|
| H00806 | Benign familial neonatal and infantile epilepsies |
Q99250
(related)
|
| H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
| H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
| H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|
| MESH or OMIM | name |
KNApSAcK
metabolite |
|---|---|---|
| D058186 | Acute Kidney Injury |
C00003494
C00003478 |
| D009374 | Neoplasms, Experimental |
C00036880
C00003491 |
| D006965 | Hyperplasia |
C00036880
C00003491 |
| D002294 | Carcinoma, Squamous Cell |
C00036880
C00003491 |
| D012878 | Skin Neoplasms |
C00003454
C00003491 |
| D007249 | Inflammation |
C00003494
C00003491 |
| D010212 | Papilloma |
C00003454
C00003491 |
| D002471 | Cell Transformation, Neoplastic |
C00003454
C00003491 |
| D005119 | Extravasation of Diagnostic and Therapeutic Materials |
C00003478
|
| D009102 | Multiple Organ Failure |
C00003494
|
| D009369 | Neoplasms |
C00003494
|
| D010049 | Ovarian Diseases |
C00003494
|
| D011014 | Pneumonia |
C00003494
|
| D011507 | Proteinuria |
C00003494
|
| D013163 | Splenomegaly |
C00003494
|
| D015470 | Leukemia, Myeloid, Acute |
C00003494
|
| D007674 | Kidney Diseases |
C00003494
|
| D005234 | Fatty Liver |
C00003494
|
| D008569 | Memory Disorders |
C00003485
|
| D056486 | Drug-Induced Liver Injury |
C00003494
|
| D003967 | Diarrhea |
C00003494
|
| D009062 | Mouth Neoplasms |
C00036880
|
| D000855 | Anorexia |
C00003494
|
| D003921 | Diabetes Mellitus, Experimental |
C00003478
|
| D009101 | Multiple Myeloma |
C00003494
|
| D020078 | Neurogenic Inflammation |
C00003478
|
| D010523 | Peripheral Nervous System Diseases |
C00003478
|
| D015427 | Reperfusion Injury |
C00003478
|
| D013276 | Stomach Ulcer |
C00003478
|
| D001750 | Urinary Bladder, Neurogenic |
C00003478
|
| D053201 | Urinary Bladder, Overactive |
C00003478
|
| D016055 | Urinary Retention |
C00003478
|
| D014839 | Vomiting |
C00003478
|
| D001932 | Brain Neoplasms |
C00003491
|
| D002277 | Carcinoma |
C00003491
|
| D006528 | Carcinoma, Hepatocellular |
C00003491
|
| D017453 | Dermatitis, Irritant |
C00003491
|
| D004487 | Edema |
C00003491
|
| D006930 | Hyperalgesia |
C00003491
|
| D017254 | Leukemic Infiltration |
C00003491
|
| D008113 | Liver Neoplasms |
C00003491
|
| D008175 | Lung Neoplasms |
C00003491
|
| D008325 | Mammary Neoplasms, Experimental |
C00003491
|
| D009336 | Necrosis |
C00003491
|
| D009361 | Neoplasm Invasiveness |
C00003491
|
| D009362 | Neoplasm Metastasis |
C00003491
|
| D010190 | Pancreatic Neoplasms |
C00003491
|
| D012868 | Skin Abnormalities |
C00003491
|
| D020301 | Vasospasm, Intracranial |
C00003491
|